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Small non-coding RNA CjNC110 influences motility, autoagglutination, AI-2 
localization, and chicken colonization in Campylobacter jejuni 
Abstract 
Small non-coding RNAs are involved in many important physiological functions in pathogenic 
microorganisms. Previous studies have identified the presence of non-coding RNAs in the major zoonotic 
pathogen Campylobacter jejuni, however, few have been functionally characterized to date. CjNC110 is a 
conserved ncRNA in C. jejuni, located downstream of the luxS gene which is responsible for the 
production of the quorum-sensing molecule autoinducer-2 (AI-2). In this study, we utilized strand specific 
high-throughput RNAseq to identify potential targets or interactive partners of CjNC110 in a sheep 
abortion clone of C. jejuni. This data was utilized to focus further phenotypic evaluation of the role of 
CjNC110 in growth, motility, autoagglutination, quorum sensing, and chicken colonization in C. jejuni. 
Inactivation of the CjNC110 ncRNA led to a statistically significant decrease in autoagglutination ability as 
well as increased motility when compared to wild-type. Extracellular AI-2 detection was decreased in 
ΔCjNC110, however, intracellular AI-2 accumulation was significantly increased with a concurrent 
increase in LuxS expression, suggesting a key role of CjNC110 in modulating the transport of AI-2. 
Notably, ΔCjNC110 also showed a significant defect in the ability to colonize chickens. Complementation 
of CjNC110 restored all phenotypic changes back to wild-type levels. The collective results of the 
phenotypic and transcriptomic changes observed in our data provide valuable insights into the 
pathobiology of C. jejuni sheep abortion clone and strongly suggest that CjNC110 plays an important role 
in regulation of energy taxis, flagellar glycosylation, cellular communication via quorum sensing, and 
chicken colonization in this important zoonotic pathogen. 
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Abstract 26 
Small non-coding RNAs are involved in many important physiological functions in 27 
pathogenic microorganisms. Previous studies have identified the presence of non-coding RNAs 28 
in the major zoonotic pathogen Campylobacter jejuni, however, few have been functionally 29 
characterized to date. CjNC110 is a conserved ncRNA in C. jejuni, located downstream of the 30 
luxS gene which is responsible for the production of the quorum-sensing molecule autoinducer-2 31 
(AI-2).  In this study, we utilized strand specific high-throughput RNAseq to identify potential 32 
targets or interactive partners of CjNC110 in a sheep abortion clone of C. jejuni. This data was 33 
utilized to focus further phenotypic evaluation of the role of CjNC110 in growth, motility, 34 
autoagglutination, quorum sensing, and chicken colonization in C. jejuni. Inactivation of the 35 
CjNC110 ncRNA led to a statistically significant decrease in autoagglutination ability as well as 36 
increased motility when compared to wild-type. Extracellular AI-2 detection was decreased in 37 
∆CjNC110, however, intracellular AI-2 accumulation was significantly increased with a 38 
concurrent increase in LuxS expression, suggesting a key role of CjNC110 in modulating the 39 
transport of AI-2. Notably, ∆CjNC110 also showed a significant defect in the ability to colonize 40 
chickens. Complementation of CjNC110 restored all phenotypic changes back to wild-type 41 
levels. The collective results of the phenotypic and transcriptomic changes observed in our data 42 
provide valuable insights into the pathobiology of C. jejuni sheep abortion clone and strongly 43 
suggest that CjNC110 plays an important role in regulation of energy taxis, flagellar 44 
glycosylation, cellular communication via quorum sensing, and chicken colonization in this 45 
important zoonotic pathogen. 46 
Introduction 47 
Campylobacter jejuni is a major foodborne and zoonotic pathogen that causes enteritis in 48 
humans [1]. A sheep abortion (SA) clone, with IA3902 as the prototype strain, has recently 49 
emerged as the predominant cause of ovine abortion [2] and as an important pathogen in 50 
foodborne outbreaks of human gastroenteritis [3] in the United States.  C. jejuni clone SA is also 51 
widely distributed in the cattle population in the U.S. [4]. The genome of IA3902 is quite 52 
syntenic with that of C. jejuni type-strain NCTC 11168 [5] although it is much more virulent 53 
than NCTC 11168 in inducing systemic infection and abortion in animals. Despite its 54 
hypervirulence, C. jejuni IA3902 does not harbor any virulence factors known to be associated 55 
with abortion in C. fetus subsp. fetus [6, 7]. Previously, the luxS gene, which mediates 56 
autoinducer-2 (AI-2) production, and the genes coding capsular polysaccharide have been 57 
identified as critical for intestinal colonization and/or translocation across gut epithelium into the 58 
bloodstream [8] [9].  Point mutations in the major outer membrane protein encoded by porA have 59 
also been shown to be sufficient to cause the abortion phenotype when compared to the syntenic 60 
non-abortive strain NCTC 11168 [10].  The fact that relatively mild changes in genomic 61 
sequences have led to significantly enhanced ability to cause disease by C. jejuni IA3902, as 62 
described above, suggests that even slight differences in sequence variations or gene regulation 63 
may have a major impact on virulence variation among differing strains of C. jejuni.  64 
C. jejuni has only three known sigma factors that regulate gene transcription: σ70 65 
(encoded by rpoD), σ54 (encoded by rpoN) and σ28 (encoded by fliA) [11]. Besides control at the 66 
transcriptional level, regulation of gene expression can also occur by post-transcriptional 67 
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modulation of mRNA translation, stability and processing, for which small non-coding RNAs are 68 
the primary players [12-14]. Non-coding RNAs (ncRNAs) can be rapidly produced and serve to 69 
regulate multiple different targets within a cell in a variety of ways to coordinate rapid responses 70 
to changing environments.  Thus, regulation of cellular processes by ncRNAs can provide 71 
several advantages to the bacteria when compared to the traditional model of protein-mediated 72 
regulation [15].  73 
Prior to completion of the transcriptional start site map via high throughput RNA 74 
sequencing (RNAseq) of H. pylori [16], the ε-proteobacteria were thought not to be capable of 75 
using small and antisense RNA as a regulatory mechanism, partly due to a lack of the small RNA 76 
chaperone protein Hfq [17]. Indeed, attempts using computational approaches to identify 77 
ncRNAs in Campylobacter failed to yield any potential candidates, with only 3 potential loci 78 
being identified in Helicobacter [18]. Recently, clear evidence that C. jejuni also harbors these 79 
important regulators has been published, revealing the existence and expression of a wealth of 80 
ncRNAs present in strains such as NCTC 11168, 81-176, 81116, RM1221 and IA3902 [19-24]. 81 
Dugar et al. [21], when comparing the transcriptomes of 4 different C. jejuni isolates, observed a 82 
large variation in transcriptional start sites as well as expression patterns of both mRNA and 83 
ncRNA between strains. This suggests that variations in the existence and expression of ncRNAs 84 
even among closely related strains may play a role in differentiating virulence. Despite these 85 
advances, identification of the functions of ncRNAs in Campylobacter has been slow to follow, 86 
with most lacking functionally characterization.  87 
The first report attempting to elucidate the role of two previously identified non-coding 88 
RNAs in C. jejuni suggests these ncRNAs may play a role in flagellar biosynthesis; however, the 89 
authors were unable to demonstrate phenotypic changes following inactivation of either non-90 
coding RNA [25]. A later paper, however, did establish the role of an RNA antitoxin (cjrA) as 91 
the first noncoding antisense small RNA functionally characterized in Campylobacter to date 92 
[26].  Beyond simply establishing the existence of non-coding RNA transcripts in 93 
Campylobacter, there is critical need to continue to determine the physiological functions of 94 
these potential regulators in this important zoonotic pathogen. 95 
Our previous work has demonstrated the in vivo and in vitro expression of numerous 96 
ncRNAs in C. jejuni IA3902 [24], including several that are conserved in other strains of 97 
Campylobacter [21]. One of the expressed ncRNAs identified in our study, the conserved small 98 
RNA CjNC110, is located in the intergenic region immediately downstream of the luxS gene.  99 
This ncRNA was of particular interest to our group as previous work in our lab has already 100 
highlighted the importance of the luxS gene in the virulence of C. jejuni [8]. In Campylobacter, 101 
the luxS gene is known to serve two important functions, production of the quorum sensing 102 
molecule autoinducer-2 (AI-2) and conversion of S-ribosylhomocysteine to homocysteine in the 103 
active methyl cycle (AMC) [27]. Of particular note, following the identification of CjNC110, it 104 
has also been suggested that different methods of generation of the luxS mutation may have led 105 
to polar effects on this downstream ncRNA that may help explain observed differences in 106 
phenotypes and gene expression between studies of luxS mutants in Campylobacter [28].   107 
Based on these observations, in this study we chose to focus on elucidating the role of 108 
CjNC110 in the pathobiology of C. jejuni IA3902. Specifically, we investigated the effect of 109 
mutagenesis of either CjNC110 or luxS as well as combined mutation of both genes on the 110 
transcriptional landscape during exponential and stationary stages of growth of C. jejuni IA3902 111 
using high-throughput RNA sequencing (RNAseq). Using RNAseq, we successfully 112 
demonstrated differences in the transcriptional landscape between our mutant constructs and 113 
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IA3902 wild-type.  Based on the RNAseq data, we then utilized several phenotypic models to 114 
further demonstrate that inactivation of CjNC110 affects motility, autoagglutination activity, 115 
autoinducer-2 (AI-2) activity and chicken colonization. The work presented here provides 116 
compelling evidence that expression of the ncRNA CjNC110 is important for the pathobiology 117 
of C. jejuni IA3902.  118 
Materials and methods 119 
Ethics Statement 120 
All studies involving animals were approved by the Iowa State University Institutional Animal 121 
Care and Use Committee (IACUC) prior to initiation (1-18-8675-G) and followed all appropriate 122 
animal care guidelines as set forth in the “Public Health Service Policy on Humane Care and Use 123 
of Laboratory Animals” developed by the U.S. Department of Health and Human Services, 124 
National Institutes of Health Office of Laboratory Animal Welfare.  Humane euthanasia was 125 
performed using carbon dioxide asphyxiation as recommended by the American Veterinary 126 
Medical Association “Guidelines for the Human Euthanasia of Animals.” 127 
Bacterial strains, plasmids, primers and culture conditions 128 
 C. jejuni IA3902 was initially isolated from an outbreak of sheep abortion in Iowa during 129 
2006 and has been utilized by our laboratory as the prototypical isolate of clone SA [2]. W7 is a 130 
highly motile variant of the commonly utilized laboratory strain C. jejuni NCTC 11168 [8]. C. 131 
jejuni strains and their isogenic mutants were routinely grown in Mueller-Hinton (MH) broth or 132 
agar plates (Becton-Dickinson, Franklin Lakes, NJ) at 42°C under microaerophilic conditions 133 
(5% O2, 10% CO2, 85% N2). For the mutant strains containing a chloramphenicol resistance 134 
cassette, 5 μg/mL chloramphenicol was added to either the broth or agar plates when appropriate. 135 
For strains containing a kanamycin resistance cassette, 30 μg/mL kanamycin was added to either 136 
the broth or agar plates when appropriate.  137 
For genetic manipulations, Escherichia coli competent cells were grown at 37°C on 138 
Luria-Bertani (LB) agar plates or broth (Becton-Dickinson, Franklin Lakes, NJ) with shaking at 139 
125 rpm. When appropriate, 50 μg/mL kanamycin, 20 μg/mL chloramphenicol or 100 μg/mL 140 
ampicillin was added to the broth or agar plates for selection of colonies. Vibrio harveyi strains 141 
were grown in autoinducer broth (AB) at 30°C with shaking at 175 rpm as described previously 142 
[29]. 143 
All strains used in this study are described in Table 1, with all relevant plasmids listed in 144 
Table A in S1 Appendix and primer sequences and LNA probe sequence in Table B in S1 145 
Appendix. All strains were maintained in 20% glycerol stocks at -80°C and passaged from those 146 
stocks as needed for experimental procedures.  147 
 148 
 149 
 150 
 151 
 152 
 153 
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 155 
Table 1. Bacterial strains utilized in this study. 156 
Strain Description Source or Reference 
Campylobacter jejuni 
  W7 Wild-type motile variant of NCTC 11168  [8]  
W7 ∆CjNC110 W7 ∆CjNC110::CmR This study 
Sheep Abortion (SA) IA3902 Wild-type C. jejuni  [2]  
IA3902 ∆CjNC110 IA3902 ∆CjNC110::CmR This study 
IA3902 ∆luxS IA3902 ∆luxS::KanR [30]   
IA3902 ∆CjNC110∆luxS IA3902 ∆CjNC110::CmR  ∆luxS::KanR This study 
IA3902 ∆CjNC110c IA3902 ∆CjNC110::CmR  CjNC110::KanR This study 
   Escherichia coli 
  
DH5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
New England Biolabs, 
Ipswich, MA 
  Vibrio harveyi    
BB152 AI-1-/AI-2+; luxM::Tn5 [29]  
BB170 AI-2 reporter strain; luxN::Tn5 [31]  
KanR = kanamycin resistance cassette 
 CmR = chloramphenicol resistance cassette 
  157 
Creation of C. jejuni ∆CjNC110 and ∆CjNC110∆luxS mutants in 158 
IA3902 159 
 An isogenic CjNC110 mutant of C. jejuni IA3902 was constructed via deletional 160 
mutagenesis utilizing a combination of synthetic double-stranded DNA (dsDNA) fragments and 161 
traditional cloning methods. Based on previously published data depicting the proposed 162 
transcriptional start site for CjNC110 [21], the coding region of CjNC110 in IA3902 and the 163 
prototypical C. jejuni strain 11168 were first confirmed to be identical. Then, a 200 bp section of 164 
the IA3902 genome starting 20 bp upstream and including the entire 137 nt transcript of the 165 
CjNC110 sequence as predicted in Dugar et al. [21] was replaced with 820 bp of the promoter 166 
and coding sequence of the chloramphenicol acetyltransferase (cat) gene of Campylobacter coli 167 
plasmid C-589 [32]. Synthetic dsDNA including approximately 500 bp upstream and 500 bp 168 
downstream of the region replaced with the cat cassette was then synthesized in 4 fragments of 169 
500 bp each with overlapping homologous ends (Integrated DNA Technologies, Coralville, IA). 170 
The Gibson Assembly method was then utilized to assemble the synthetic dsDNA fragments [33] 171 
using the Gibson Assembly Master Mix (New England Biolabs, Ipswich, MA). Following 172 
assembly, primers (CJnc110F2 and CJnc110R2) were designed to amplify a 1785 bp product of 173 
the assembled dsDNA; PCR amplification was achieved using TaKaRa Ex Taq DNA 174 
Polymerase (ClonTech, Mountain View, CA). This amplified PCR product was then cloned into 175 
the pGEM-T Easy Vector using T4 ligase (Promega, Madison, WI), resulting in the construction 176 
of pCjNC110::cat which was then transformed into chemically competent E. coli DH5α (New 177 
England Biolabs, Ipswich, MA). Transformants were then selected on LB agar plates containing 178 
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chloramphenicol (20 μg/ml), ampicillin (100 μg/ml), and ChromoMax IPTG/X-Gal Solution 179 
(Fisher Scientific, Pittsburgh, PA). pCjNC110::cat was purified from the transformed E. coli 180 
using the QIAprep Miniprep kit (QIAGEN, Germantown, MD) and confirmed by PCR to contain 181 
the construct again using the CJNC110F2 and CJNC110R2 primers.  182 
The pCjNC110::cat plasmid DNA was then introduced to C. jejuni W7 as a suicide 183 
vector and the deletion transferred into the genome of C. jejuni W7 via homologous 184 
recombination. Transformants were selected on MH agar plates containing chloramphenicol (5 185 
μg/ml) and deletional mutagenesis was again confirmed via PCR analysis and Sanger sequencing 186 
to create C. jejuni W7∆CjNC110. Following confirmation, natural transformation was used to 187 
move the gene deletion into C. jejuni IA3902 as previously described [34] to create C. jejuni 188 
IA3902∆CjNC110. Natural transformation was again used to move the CjNC110 gene deletion 189 
into the previously created luxS insertional mutant C. jejuni IA3902∆luxS [8] to create the 190 
double knockout mutant C. jejuni IA3902∆CjNC110∆luxS. Transformants were selected on MH 191 
agar plates containing chloramphenicol (5 μg/mL) and kanamycin (30 μg/mL) and confirmed via 192 
PCR analysis and Sanger sequencing of the CjNC110 region along with the entire upstream 193 
(luxS) and downstream (CjSA_1137) genes using primers Cj1198F1 and Cj1199R3. All colonies 194 
were screened for presence/absence of motility as described below, and only colonies with 195 
verified motility were used for future studies.  Expression of CjNC110 in wild-type and 196 
elimination of expression in the ∆CjNC110 mutant was confirmed via northern blot analysis 197 
using an LNA custom designed probe (QIAGEN) and 15μg of total RNA as previously described 198 
[35].  199 
 200 
Creation of C. jejuni ∆CjNC110 complement in IA3902 201 
Complementation of ∆CjNC110 was achieved via insertion of the coding region into the 202 
intergenic region of the 16S and 23S rRNA operon (rrs-rrl) of IA3902∆CjNC110 via 203 
homologous recombination using plasmid pRRK.  A copy of the CjNC110 gene including 190bp 204 
upstream of the transcription initiation location (total of 570bp) was cloned into an XbaI site of 205 
pRRK located upstream of the kanamycin resistance determinant to create pCjNC110c as 206 
previously described in our lab [36] with some modifications of the original protocol [37].   Briefly, 207 
the CjNC110 gene and flanking regions of IA3902 were amplified using forward and reverse 208 
primers designed with an XBaI restriction enzyme site (CjNC110cF1 and CjNC110cR1).  209 
Following PCR amplification with TaKaRa Ex Taq DNA Polymerase (ClonTech, Mountain 210 
View, CA), the PCR product and pRRK plasmid were digested with the XBaI restriction 211 
endonuclease (New England Biolabs, Ipswich, MA).  The digested plasmid was then incubated 212 
twice with Antarctic Phosphatase (New England Biolabs, Ipswich, MA) to prevent self-ligation 213 
of cut plasmid.  Following ligation and transformation, transformants were selected on LB agar 214 
plates containing chloramphenicol (20 μg/ml) and kanamycin (50 μg/ml kanamycin) yielding a 215 
plasmid containing the construct pRRK::CjNC110 in E. coli DH5α.  Following PCR 216 
confirmation and Sanger sequencing to confirm preservation of correct gene sequence, the 217 
plasmid was then utilized as a suicide vector and the gene was inserted into the intergenic region 218 
of the 23S rRNA operon (rrs-rrl) of IA3902∆CjNC110 via homologous recombination to 219 
generate IA3902∆CjNC110c transformants.  The transformants were selected on MH agar plates 220 
containing chloramphenicol (5 μg/ml) and kanamycin (30 μg/ml) and confirmed via PCR 221 
analysis and Sanger sequencing to contain both the expected ∆CjNC110 deletional mutation and 222 
∆CjNC110c insertion, validating successful genetic complementation.  All positive colonies 223 
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were screened for presence/absence of motility as described below and a motile complement was 224 
selected to create IA3902∆CjNC110c. 225 
 226 
Growth curves 227 
Two separate growth curves were completed in triplicate utilizing the same method as 228 
described below with the only variation being the addition of the complement strain ∆CjNC110c 229 
to the second growth curve.  To begin the growth curve, the A600 of overnight cultures were 230 
adjusted to 0.5 using sterile MH broth on a Genesys 10S VIS spectrophotometer (Thermo 231 
Scientific, Waltham, MA). Cultures were then diluted 1:10 for a final targeted starting A600 of 232 
0.05 in 90 mL sterile MH broth and placed in a sterile 250 mL Erlenmeyer glass flask. Cultures 233 
were incubated at 42°C under microaerophilic conditions with shaking at 125 rpm for 30 hours 234 
with removal of samples from the flasks at designated time points [3, 6, 9, 12, 24, 27 (2
nd
 growth 235 
curve only) and 30 hours].  For the first growth curve (which included the following strains: 236 
IA3902 wild-type, ∆CjNC110, ∆luxS and ∆CjNC110∆luxS), samples were processed as 237 
described below for RNA isolation as well as assessed for A600 and actual colony counts using 238 
the drop-plate method as previously described [38]. For the second growth curve (which 239 
included ∆CjNC110c in addition to the four previous strains), samples were collected and 240 
processed for A600 and as described below for assessment of AI-2 levels via the bioluminescence 241 
assay.  The A600 over time were statistically analyzed for the two independent growth curves, 242 
using a two-way ANOVA with repeated measures and Dunnett’s multiple comparison test 243 
(GraphPad Prism).  244 
 245 
Total RNA extraction  246 
Broth culture samples processed for total RNA extraction were either centrifuged at 8000 247 
x g for 2 minutes (for sequencing and qRT-PCR) or 10,000 x g for 4 minutes (Northern blot) at 248 
4°C immediately following collection. Following pelleting of the cells, the supernatant was 249 
decanted and 1 mL QIAzol Lysis Reagent (QIAGEN) was added to resuspend the cell pellet and 250 
protect the RNA. QIAzol-protected cultures were then stored at -80°C for up to two months prior 251 
to proceeding with total RNA isolation. Total RNA isolation was performed using the miRNeasy 252 
Mini Kit (QIAGEN) followed by purification using the RNeasy MinElute Cleanup kit 253 
(QIAGEN) as previously described [24].  RNA quality was measured using the Agilent 2100 254 
Bioanalyzer RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA) and all RNA samples 255 
utilized for downstream RNAseq library preparation had an RNA integrity number (RIN) of 256 
>9.0, indicating high quality RNA. Verification of complete removal of any contaminating DNA 257 
was performed via PCR amplification of a portion of the CjSA_1356 gene, which is unique to C. 258 
jejuni IA3902, using primers SA1356F and SA1356R [39].  259 
 260 
RNAseq library preparation and sequencing 261 
The 3 hour (exponential phase) and 12 hour (stationary phase) timepoints were selected 262 
for RNAseq analysis based on assessment of log10 CFU/mL (Fig A in S3 Appendix). 2.5 µg of 263 
confirmed DNA-free total RNA was treated with Ribo-Zero rRNA Removal Kit for Bacteria 264 
according to the manufacturer’s instructions (Illumina, San Diego, CA). Following rRNA 265 
removal, the ribosomal depleted total RNA was purified using the RNeasy MinElute Cleanup kit 266 
(QIAGEN) using the same modifications as described previously [24]. Following clean-up, the 267 
RNA quality, quantity, and rRNA removal efficiency was then analyzed via the Agilent 2100 268 
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Bioanalyzer RNA 6000 Pico kit (Agilent Technologies). Library preparation for sequencing on 269 
the Illumina HiSeq platform was completed using the TruSeq stranded mRNA HT library 270 
preparation kit (Illumina) with some modifications as described previously [24]. The pooled 271 
library was then submitted to the Iowa State University DNA Facility and sequenced on an 272 
Illumina HiSeq 2500 machine in high-output single read mode with 100 cycles.  273 
 274 
Differential gene expression analysis of RNAseq data 275 
 Rockhopper (http://cs.wellesley.edu/~btjaden/Rockhopper/) was used to analyze the 276 
differences in gene expression between strains and timepoints; the standard settings of the 277 
program were utilized for analysis [40]. Following computational analysis via Rockhopper, a 278 
change in gene expression was deemed significant when the Q-value (false discovery rate) was 279 
below 5% and a >1.5 fold change in expression was observed. Visual assessment of read count 280 
data was performed using the Integrated Genome Viewer (IGV) 281 
(https://www.broadinstitute.org/igv/) [41, 42]. Assessment of function of the differentially 282 
expressed genes was performed using the Clusters of Orthologous Groups (COG) [43] as 283 
previously described in IA3902 [5]. Venn diagrams were used to depict overlap of genes 284 
differentially regulated in multiple mutant strains and were generated using BioVenn [44] 285 
(http://www.cmbi.ru.nl/cdd/biovenn/index.php). Kegg Pathways was used to perform metabolic 286 
pathway analysis [45] (http://www.genome.jp/kegg/pathway.html).  287 
 288 
Northern Blot 289 
For northern blot detection of CjNC110, bacterial cells from WT, ΔCjNC110, and 290 
ΔCjNC110c were grown to exponential phase of growth in MH broth and total RNA isolation 291 
performed as described above. The total RNA input was normalized to 15 μg using Qubit BR 292 
RNA Assay Kit (Invitrogen, USA) for each respective strain. For northern blot detection, total 293 
RNA from bacterial cells (15 μg) and a pre-stained DynaMarker RNA High Ladder 294 
(Diagnocine LLC, Hackensack, NJ) were loaded onto 1.3% denaturing agarose gel (Bio-rad, 295 
Hercules, CA), consisting of 1x MOPS buffer (Fisher, USA)  and 5% solution of 37% 296 
formaldehyde (Fisher, USA), electrophoresed at 100V for 1h and transferred to positively-297 
charged nylon membrane (Roche, Indianapolis, IN) using a Vacuum Blot System (Bio-Rad) 298 
transferring at 60mbar for 2 hours. To make RNA cross-linking solution, 245 μl of 12.5 M 1-299 
methylimidazole (Sigma, St. Louis, MO) was suspended in 9 mL RNase free water, maintaining 300 
a pH of 8.0. Then, a total of 0.753 g 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 301 
was added and the total volume adjusted to 24 mL with RNase-free water. RNA was then cross-302 
linked to the membrane by placing the nylon membrane, side devoid of RNA, on saturated 3mm 303 
Whatman chromatography paper and incubating it in the freshly prepared EDC solution at 60°C 304 
for 2 hours. After cross-linking the membrane was washed with RNase-free water. Next, 305 
CjNC110-LNA probe (/5’DigN/ GCACATCAGTTTCAT/3’Dig_N/) (QIAGEN) was added to 306 
15 mL DIG EasyHyb Buffer (Roche) to reach a final concentration of 25 ng/mL.  307 
Hybridization was performed using a hybridization oven and bottle, rotating at 42°C for 12 308 
hours. After overnight incubation, subsequent washes and incubations were performed again 309 
using the hybridization chamber. The blot was first washed twice with low stringency buffer (2x 310 
SSC, 0.1% SDS) for 15 minutes at 50°C, and three times with high stringency buffer (0.1% SSC 311 
and 0.1% SDS) for 10 minutes at 50°C.  DIG Washing and DIG Blocking Buffers were prepared 312 
using the DIG Wash and Block Set (Roche, USA). The blot was washed twice with Washing 313 
Buffer for 10 minutes at 37°C. Next, the blot was incubated in 1x Blocking Buffer for 3 hours at 314 
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room temperature. DIG antibody solution was added by mixing Blocking Buffer with DIG 315 
antibody at a ratio of 1:5,000. The blot was then incubated for 30 minutes at room temperature. 316 
Next, excess DIG antibody was removed by rinsing with the DIG Washing Buffer a total of four 317 
times for 15 minutes each. For development and detection, the membrane was placed in 318 
Development/Detection Buffer for 10 minutes, and 2 mL ready-to-use CDP-Star (Roche, 319 
USA) was added to cover the blot completely. To image the blot, Chemidoc Imager (Bio-Rad) 320 
was used, exposing the blot for 5 minutes on the chemiluminescence setting. Image layout and 321 
annotations were performed using GraphPad Prism. ImageLab software (Bio-Rad) was used to 322 
generate a standard curve using RF and nt size of the ladder to predict the average band size of 323 
the target RNA.  324 
 325 
TargetRNA2 and RNAFold 326 
 To attempt to computationally determine potential targets regulated by CjNC110 and to 327 
compare results to our RNAseq data, the freely available TargetRNA2 program 328 
(http://cs.wellesley.edu/~btjaden/TargetRNA2/) was utilized to predict potential targets of 329 
interest a priori [46]. The standard program settings were utilized, which included searching the 330 
region 80 nt upstream and 20 nt downstream of the predicted translational start site of all genes 331 
in the IA3902 genome.  To attempt to predict the secondary structure of the CjNC110 non-332 
coding RNA, the standard settings of the RNAFold webserver was used for prediction analysis 333 
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi) [47, 48]. Both the 137 nt read length predicted 334 
from Dugar et al. [21] and the 152 nt length predicted from our northern blot results were used 335 
for analysis via these methods. 336 
 337 
Enumeration of luxS Transcriptional Levels Utilizing qRT-PCR 338 
  To validate the RNAseq results and compare luxS expression between mutants, 339 
quantitative reverse transcriptase PCR (qRT-PCR) was performed using total RNA isolated from 340 
IA3902 wild-type, ∆CjNC110, and ∆CjNC110c purified in three separate biological replicates of 341 
broth cultures grown to 12 hours from the second growth curve described above.  Total RNA 342 
was extracted and qRT-PCR was performed using the iScript cDNA Synthesis Kit (Bio-Rad, 343 
Hercules, CA) and 1000 ng of total RNA according to the manufacturer's instructions as 344 
previously described [49]. Each sample was normalized to the same starting amount of cDNA 345 
using Qubit BR DNA Assay Kit (Invitrogen). cDNA purity was measured using the NanoDrop 346 
ND-1000 spectrophotometer. qPCR assays were run using the SsoAdvanced Universal 347 
SYBR Green Supermix (Bio-Rad, Hercules, CA) and the CFX Maestro Real-Time PCR 348 
detection system (Bio-Rad). Dilutions of cDNA template for both standards and all unknowns 349 
were run in triplicate with reaction volumes of 10 μl.  Amplification of converted cDNA 350 
occurred with 35 cycles of denaturation at 95°C for 10 seconds and then annealing for each 351 
primer pair (Table 3) at 58°C for 30 seconds. Prior to analysis, both standards curves (16S and 352 
luxS) were experimentally validated to have high efficiency 90%> of amplification and precision 353 
R
2
=0.98 or greater. Relative fold change in luxS mRNA expression between IA3902 wild-type, 354 
∆CjNC110, and ∆CjNC110c was calculated using the ISU Gallup Method Equation [50]. 355 
Statistical analyses was performed using one-way ANOVA (GraphPad Prism) to determine 356 
significance in gene expression levels. A p-value of <0.05 was considered significant.  357 
 358 
Vibrio harveyi bioluminescence assay  359 
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 Culture samples collected from time points 3, 6, 9 and 12 hours (2 mL each timepoint) 360 
from the second growth curve described above were centrifuged at 20,000 x g for 5 minutes at 361 
4ºC. The supernatant was then removed from the cell pellet and filter-sterilized using a 0.2 μm 362 
syringe filter to create cell-free supernatant representative of the extracellular environment (E-363 
CFS); both the E-CFS and the remaining cell pellet were then frozen at -80ºC. For processing of 364 
the cell pellet to create intracellular cell-free supernatant (I-CFS), samples were thawed on ice 365 
and then washed twice with PBS; following each wash, the cells were spun again at 8000 x g and 366 
the resulting supernatant was completely removed from the cell pellet. Next, the cell pellet was 367 
resuspended in 600 μl of ice-cold MH broth. The resuspended cell pellets were then lysed using a 368 
Bullet Blender (NextAdvance, Troy, NY). To lyse the cells, 1.5 mL microcentrifuge tubes 369 
(Corning, Corning, NY) were loaded with sterilized 0.9-2.0 mm diameter stainless steel beads 370 
(NextAdvance). The Bullet Blender was used for 5 minutes at max speed and stored at 4°C. 371 
Lysed cellular debris were spun at 8000 x g for 2 minutes using a microcentrifuge, and the 372 
resulting supernatant filtered using a 0.20 μm sterile syringe filter, resulting in intracellular cell-373 
free supernatant (I-CFS).  Both E-CFS and I-CFS were frozen at -80 ºC until proceeding with the 374 
bioluminescence assay. 375 
Autoinducer-2 levels within the collected supernatant for both intracellular (I-CFS) and 376 
extracellular (E-CFS) samples were then enumerated using the Vibrio harveyi bioluminescence 377 
assay as previously described [51]. Briefly, 10 µL of each CFS sample was added to 90 µL AB 378 
media containing a 1:5000 dilution of the reporter strain, V. harveyi strain BB170 [31] in 379 
triplicate. Relative light units (RLU) were measured every 15 minutes over 8 hours using the 380 
FLUOstar Omega (BMG Labtech, Ortenburg, Germany). MH broth and AB media were used as 381 
negative controls, while E-CFS collected from V. harveyi strain BB152 [29] was used as a 382 
positive control. The timepoints utilized for analysis were those occurring during the nadir of 383 
values for the negative control wells and at a standardized duration of time (approximately 3 384 
hours) following initiation of increasing values for the positive wells.  Results reported are the 385 
average of three independent growth curves with three technical replicates used at each 386 
timepoint. Statistical analysis was conducted using a two-way ANOVA with repeated measures 387 
and Sidak’s multiple comparisons test (GraphPad Prism).  A p-value of <0.05 was considered 388 
significant. 389 
 390 
Motility assay 391 
Motility was determined via inoculation of plates consisting of MH broth with 0.4% agar 392 
as previously described in our laboratory [8]. Briefly, the A600 of overnight cultures was adjusted 393 
to 0.3 using sterile MH broth on a Genesys 10S VIS spectrophotometer (Thermo Scientific). A 394 
1 µL volume inoculation stick was then dipped into a set volume of the standardized culture 395 
contained in the bottom of a 15 mL conical tube which was then used to make a stab inoculation 396 
into the center of the freshly made motility agar (MH broth with 0.4% Bacto agar) with a new 397 
inoculation stick for each plate. Plates were incubated at 42°C under microaerophilic conditions 398 
as described above with the exception that the plates were incubated right-side up and in a single 399 
layer. Measurement of the outermost reach of the halo was performed at 30 hours following 400 
inoculation for the first set of experiments and at 24 hours for the second set of experiments. All 401 
strains were assessed for average motility using six biological replicates consisting of six 402 
technical replicates during each independent study. The six experiments were statistically 403 
analyzed using a one-way ANOVA and differences between each strain assessed via Tukey’s 404 
multiple comparisons test (GraphPad Prism). A p-value of <0.05 was considered significant. 405 
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 406 
Autoagglutination assay 407 
Autoagglutination was assessed according to the method described previously [52] with 408 
some modifications. Briefly, the A600 of overnight cultures was adjusted to 1.0 in sterile 409 
Dulbecco’s phosphate buffered saline (PBS) (Corning cellgro, Manassas, VA) using a Genesys 410 
10S VIS spectrophotometer (Thermo Scientific). The suspension was then aliquoted (2 mL 411 
each) into standard glass culture tubes. One subset of cultures were kept at controlled room 412 
temperature (25°C) under microaerophilic conditions; the others were incubated at 37°C 413 
microaerophilic. At 24 hours, 1 mL of the upper aqueous phase was carefully removed and A600 414 
measured to determine autoagglutination activity. All strains were assessed in quadruplicate at 415 
each temperature in three independent experiments. The three experiments were statistically 416 
analyzed using a one-way ANOVA and differences between each strain assessed via Tukey’s 417 
multiple comparisons test (GraphPad Prism). A p-value of <0.05 was considered significant. 418 
 419 
Liquid Chromatography with Tandem Mass Spectrometry-Based 420 
Proteomic Analysis 421 
For extraction of whole cell protein, bacterial cells from IA3902 wild-type, ∆CjNC110 422 
and ∆CjNC110c were grown to exponential phase of growth at 16 hours on MH agar. Lawn 423 
cultures were then harvested from the plates using 1 mL of MH broth and resuspended in MH 424 
broth. Collected lawns were normalized to an A600 of 0.2 and aliquoted into 1 mL technical 425 
replicates. This was repeated for three biological replicates. To wash the cells, each aliquot was 426 
re-suspended in 1 mL of PBS, cells were spun down at 8000 x g for 3 minutes, and the 427 
supernatant was decanted. Next, 50 µl of lysis buffer (filtered sterilized water + 1% Triton X-428 
100) was added to the protein pellets for resuspension (adapted from [53]).  The cells were then 429 
mechanically sheared by boiling at 96°C for 5 minutes followed by rapid pipetting. After 3 430 
cycles of boiling-shearing, total cell extracts were centrifuged at 10,000 × g for 5 min to remove 431 
cell debris. The supernatants were collected, and protein concentration was determined using the 432 
Qubit Protein Assay and Fluorometer (Invitrogen). Crude protein was then submitted to the 433 
Iowa State Protein Facility. Crude protein extracts were digested overnight in solution with 434 
trypsin/Lys-C (25-50 µg). After digestion, Pierce Peptide Retention Time Calibration Mixture 435 
(PRTC) (ThermoFisher Scientific) was spiked into the samples to serve as an internal control (25 436 
fmol/µL). The PRTC areas were used to normalize collision energies, retention times, and peak 437 
intensities to allow for quantitative analysis between samples. 438 
 Proteomic analysis was performed via liquid chromatography with tandem mass 439 
spectrometry (LC-MS/MS) using a Q Exactive™ Hybrid Quadrupole-Orbitrap Mass 440 
Spectrometer (Thermo Scientific) system. The system was coupled with EASY-nLC 1200 441 
nanopump with integrated auto-sampler (Thermo Scientific).  Liquid chromatography was 442 
used to separate the peptides followed by fragmentation and MS/MS analysis. The resulting 443 
intact fragmentation pattern was compared to a theoretical fragmentation pattern (MASCOT) to 444 
find peptides that can be used to identify high-confidence proteins. Minora Feature Detector was 445 
used for label-free quantification to detect and quantify discovered isotopic clusters.   446 
Abundances of proteins were compared by grouping by strain and averaging the 447 
abundances of each protein identified. For data filtering and data imputation, PANDA-view, a 448 
freely available proteomic software (https://sourceforge.net/projects/panda-view/), was used 449 
[54]. Briefly, only proteins identified in two out of three biological replicates were included in 450 
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analysis. Nearest neighbor (kNN) imputation was used to fill any missing protein values [55]. All 451 
data was log transformed using log2. For statistical analysis, two-way ANOVA with false 452 
discovery rate correction set at 0.05 was performed (Graphpad Prism). Graphical Hierarchical 453 
clustering heat maps were generated using freely available MetaboAnalyst software [56]. The 454 
top 20 proteins were group and analyzed using the following heat map settings: distance 455 
measurement of Euclidean and the average clustering algorithm [56, 57].  456 
 457 
Chicken colonization 458 
Chicken colonization studies were performed as previously described in our laboratory 459 
utilizing 1 day-old broiler chicks obtained from a commercial hatchery [8].  A subset of chicks 460 
from each group were screened via cloacal swabs plated on MH agar containing both selective 461 
supplement and growth supplement (MH+sel+sup) (Oxoid, ThermoFisher Scientific) and found 462 
to be negative for Campylobacter carriage prior to inoculation.  At 3 days of age, chicks were 463 
inoculated by oral gavage with 200 µl of bacterial suspension containing approximately 1 x 10
7 
464 
of one of the tested strains.  Groups of chicks inoculated with specific strains were housed in 465 
separate brooders with no contact between the groups.  At pre-determined timepoints post-466 
inoculation (5 days, 12 days, and 19 days), a minimum of 5 chicks from each group were 467 
randomly selected for humane euthanasia which was immediately followed by necropsy. Cecal 468 
contents were harvested aseptically and stored on ice until further processing could be 469 
completed. Cecal samples were then weighed and subjected to a 10-fold serial dilution series, 470 
plated on MH+sel+sup agar, and grown under routine culture conditions as described above.   To 471 
confirm that the isolates recovered were in fact the mutant strain and no cross contamination 472 
occurred, representative colonies were selected from each strain and timepoint, grown in 473 
MH+sel+sup broth, and plated on the respective antimicrobial selective agar of the mutant strain 474 
as described above. In addition, a minimum of two CFU from each group was collected for PCR 475 
analysis and confirmation of no cross-contamination between biological groups. The detection 476 
limit of the assay was determined to be 100 CFU/g; for isolates with no detectable colonies 477 
within the optimal target range of 30-300 CFU on the initial dilution plate, a count of 3 x 10
3
 was 478 
used to enable statistical analysis.  For statistical analysis, one-way ANOVA and Tukey's 479 
multiple comparison test was used to determine significant differences in colonization between 480 
biological groups (GraphPad Prism), using the null hypothesis that colonization rates between 481 
groups are the same. A p-value of <0.05 was considered significant. 482 
 483 
Data availability 484 
 485 
The RNAseq dataset generated in this publication has been deposited in the NCBI Database 486 
under BioProject ID Number PRJNA590513 487 
(http://www.ncbi.nlm.nih.gov/bioproject/590513). 488 
 489 
Results 490 
Northern blotting and RNAseq validate expression of small RNA 491 
CjNC110 and mutant constructs 492 
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To validate expression of CjNC110 in IA3902, northern blots comparing IA3902 wild-type, 493 
ΔCjNC110 and ΔCjNC110c using 15 μg of total RNA extracted at log phase of growth from 494 
cultures collected at the same OD600 were performed.  Northern blot analysis clearly 495 
demonstrates that small RNA CjNC110 is expressed by IA3902 wild-type and ΔCjNC110c but 496 
not ΔCjNC110 (Fig 1). Using ImageLab, a standard curve was generated using RF and nt size of 497 
the ladder to predict the IA3902 CjNC110 average band size, which was 152bp.  This is slightly 498 
larger than the size that was initially predicted in Dugar et al. which was 137bp [21]. 499 
Fig 1.  Northern blotting demonstrates expression of CjNC110 in wild-type IA3902 and 500 
ΔCjNC110c but not in ΔCjNC110.  Cultures for RNA extraction were collected at log phase of 501 
growth and northern blot analysis was conducted using 15 μg of total RNA in each of three 502 
separate lanes per strain tested.    503 
 The RNAseq data that was compiled for each of the mutants allowed further visualization 504 
of the unique read signature related to the mutated regions via the Integrated Genome Viewer as 505 
presented in Fig 2A and as compared to the anticipated mutated gene structure (Fig 2B). In all 506 
timepoints and replicates sequenced for the ∆CjNC110 and ∆CjNC110∆luxS mutants, no reads 507 
mapped to the reported location of the CjNC110 small RNA; this was anticipated based on the 508 
method of mutant construction which removed that entire region of the genome en bloc and 509 
replaced it with an antibiotic resistance marker. Rockhopper did fail to identify CjNC110 as a 510 
small RNA candidate in this dataset which was somewhat unexpected. Further analysis of the 511 
data revealed that expression levels of CjNC110 transcripts were relatively low in the IA3902 512 
wild-type at both stages of growth, which may explain why it was not recognized by Rockhopper 513 
as a unique ncRNA.  514 
 515 
Fig 2. Graphic view of mutations. (A) A screen capture depicting the average RNAseq 516 
expression results from IGV of the luxS and CjNC110 regions of the genome, corresponding to 517 
the genome structure as depicted in (B) of all of the strains sequencing using RNAseq.  518 
 519 
 For the ∆luxS and ∆CjNC110∆luxS mutants, the location of the insertion of the 520 
kanamycin resistance cassette into the coding sequence of the luxS gene can be directly observed 521 
as a sudden decrease in the amount of reads downstream of the location of the insert. In the 522 
∆luxS mutant, reads mapping to CjNC110 can also be seen which indicates that the mutation 523 
does not interfere with ability of the downstream small RNA to be transcribed. In the 524 
∆CjNC110∆luxS mutant, no reads are present that map to the CjNC110 coding region, 525 
confirming that both genes are inactivated in that strain.  526 
 527 
Differential gene expression analysis of RNAseq data indicates 528 
upregulation of luxS in ∆CjNC110 mutant and significant gene 529 
expression changes in ∆CjNC110∆luxS associated with flagellar 530 
biosynthesis 531 
 Overall, 24 barcoded libraries were sequenced yielding over 109 million reads, with close 532 
to 100 million high quality reads aligning to either the genome or pVir plasmid of C. jejuni 533 
IA3902 and averaging 4,553,847 reads per library (Tables C and D in S1 Appendix). The vast 534 
majority of reads (average of 83% of total reads) mapped to protein coding genes of the 535 
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chromosome, with only 7% of reads mapping to ribosomal RNA on average following rRNA 536 
depletion with Ribo-Zero (median of 3%). Over half of the libraries contained less than or equal 537 
to 3% ribosomal RNA reads, which is consistent with the manufacturer’s predicted rRNA 538 
removal efficiency. One third of the libraries did not exhibit efficient rRNA removal (>10% 539 
rRNA reads); the reason for this is unclear. Despite this difference in efficiency, all samples 540 
provided a more than adequate number of non-rRNA reads and thus were successfully utilized in 541 
the analysis.  Less than 1% of reads mapped to antisense regions of the annotated genome.  542 
A summary of the differences in numbers of genes with increased and decreased 543 
expression in the various strains and timepoints is given in Table 2, with a listing of specific 544 
genes given in Table 3. In the ∆CjNC110 mutant strain, six genes were found to be 545 
downregulated and four genes were found to be upregulated when compared to the IA3902 wild-546 
type strain during exponential growth (complete information Table E in S1 Appendix). In 547 
addition, a previously described non-coding RNA, CjNC140 [21] was found to be upregulated in 548 
the mutant condition. During the stationary phase, 16 genes were found to be downregulated and 549 
seven genes were found to be upregulated in the mutant strain when compared to wild-type. Of 550 
the regulated genes, three genes (neuB2, hisF, ptmA) were downregulated in the ∆CjNC110 551 
mutant during both the exponential and stationary phases, and one hypothetical protein coding 552 
gene (CjSA_1261) was found to be upregulated in both conditions. Of the differentially 553 
expressed genes, five separate operons predicted by Rockhopper demonstrated multiple genes 554 
within the operon affected by the mutant condition. Analysis of functionality via the COG 555 
database revealed that multiple upregulated genes (luxS, cetA, cetB) were present in the “Signal 556 
transduction mechanisms” category; multiple downregulated genes were also included in the 557 
“Cell wall/membrane biogenesis” (neuB2, ptmB, CjSA_1352) category and “Posttranslational 558 
modification, protein turnover, chaperones” (tpx, CjSA_0687) functional category. 559 
 560 
Table 2. Summary of differential gene expression results between mutant strains. 561 
  
Condition 
  
∆CjNC110 
 
∆luxS 
 
∆CjNC110∆luxS 
    3 h 12 h  
3 h 12 h 
 
3 h 12 h 
Protein-coding genes 
         Number downregulated  
 
6 16 
 
1 6 
 
61 32 
Number upregulated 
 
4 7 
 
14 6 
 
47 29 
Non-coding RNA genes 
         
Number downregulated 
 
0 0 
 
0 0 
 
  25b 2 
Number upregulated 
 
1a 0 
 
1a 0 
 
1a 0 
a = previously described ncRNA, CjNC140 [21]  
b = 17 tRNA genes, 3 known RNA genes (tmRNA, SRP, 6S) and 4 newly predicted ncRNA 
 562 
Table 3. Summary of differential gene expression (>1.5 fold change, q <0.05) in the IA3902 563 
∆CjNC110, ∆luxS and ∆CjNC110∆luxS mutants as determined by RNAseq.564 
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 Exponential (3 h) Stationary (12 h) 
 ∆CjNC110* ∆luxS* ∆CjNC110∆luxS* ∆CjNC110* ∆luxS* ∆CjNC110∆luxS* 
G
e
n
e
s 
d
o
w
n
re
gu
la
te
d
 
hisF 
pseA 
neuB2 
ptmA 
CjSA_1352 
rpsN 
CjSA_1350 CjSA_0014 
CjSA_0041 
flgD 
flgE 
CjSA_0067  
accD 
trxA 
panB 
motB 
fliN 
rpsU 
frdB 
flag 
fliS 
CjSA_0521  
CjSA_0569 
pstS 
hslV 
flgH 
flgG2 
flgG 
mogA 
aspB 
hydD 
pseB 
pseC 
CjSA_1233 
neuC2 
CjSA_1350 
CjSA_1351 
CjSA_0788 
flgL 
rpmH 
CjSA_0920  
CjSA_1093  
CjSA_1102 
dctA 
luxS 
CjSA_1182 
porA 
flgI 
CjSA_1388 
CjSA_1389 
flgK 
moaE 
nuoD 
CjSA_1562 
CjSA_1568 
CjSA_1577 
CjSA_t0035 
CjSA_t0036 
CjSA_t0037 
CjSA_t0038 
CjSA_t0039 
CjSA_t0043 
CjNC130 
secY 
rplO 
rpsE 
rplR 
rplF 
rpsH 
rpsN 
rplE 
rplX 
rplN 
rpmC 
rplP 
CjSA_CjSRP1 
CjSA_t0002 
CjSA_t0005 
CjSA_t0007 
CjSA_t0012 
CjSA_t0013 
CjSA_t0015 
CjSA_t0017 
CjSA_t0018 
CjSA_t0020 
CjSA_t0021 
CjSA_t0033 
panC 
CjSA_0559 
CjSA_0687 
Tpx 
CjSA_0785 
ciaB 
CjSA_1102 
petC 
CjSA_1137 
CjSA_1244 
hisF 
neuB2 
CjSA_1266 
ptmB 
ptmA 
CjSAt0002 
CjSA_0560 
CjSA_0620 
CjSA_1349 
CjSA_1350 
Acs 
leuC 
rnhB 
CjSA_0158 
CjSA_0160 
CjSA_0284 
motB 
trpD 
CjSA_0344 
CjSA_0372 
CjSA_0389 
CjSA_0396 
sdhA 
sdhB 
uxaA 
CjSA_0560 
CjSA_0616 
trmD 
 
aroB 
CjSA_1137 
CjSA_1164 
pyrH 
CjSA_1349 
CjSA_1350 
CjSA_1414 
Acs 
CjSA_1461 
rnhA 
CjSA_1560 
leuC 
leuB 
leuA 
CjSA_pVir0030 
G
e
n
e
s 
u
p
re
gu
la
te
d
 
CjSA_0008 
cetA 
cetB 
CjSA_1261 
CjNC140 
dnaN 
CjSA_0008  
trpF 
trpB 
CjSA_0337 
CjSA_0370 
CjSA_0732 
CjSA_1017 
CjSA_1131 
CjSA_1301 
CjSA_1352 
CjSA_1449 
CjSA_1549 
CjSA_pVir004 
CjNC140 
dnaN 
CjSA_0008 
gltD  
folk 
CjSA_0076 
CjSA_0105 
CjSA_0110 
dgkA 
pyrC 
Tal 
CjSA_0305  
trpD 
 
trpF 
trpB 
trpA 
CjSA_0337 
CjSA_0370 
CjSA_0372 
sdhA 
sdhB 
CjSA_0490 
CjSA_0491 
CjSA_0836 
Cfa 
cetB 
cetA 
CjSA_1129 
CjSA_1131 
CjSA_1145 
CjSA_1164 
cbpA 
CjSA_1259 
CjSA_1260 
CjSA_1301 
CjSA_1343 
tagF 
CjSA_1449 
rloH 
nuoM 
CjSA_1549  
euC 
leuB, 
leuA 
CjNC140 
CjSA_pVir0042 
CjSA_pVir0044 
CjSA_pVir0025 
hcrA 
CjSA_0716 
CjSA_0717 
CjSA_1107 
CjSA_1108 
omp50 
luxS 
flgE 
flgG2 
flgG 
hcrA 
CjSA_1107 
nrfA 
dsbI  
CjSA_0040 
CjSA_0041 
flgD 
flgE 
flgC 
flgB 
flgH 
flgG2 
flgG 
hcrA 
CjSA_0716 
flgS 
flgL 
CjSA_0969 
CjSA_1107 
omp50 
CjSA_1180 
pseB 
CjSA_1262 
neuB2 
neuC2 
flgI 
CjSA_1387 
flgK 
CjSA_1562 
p19 
CjSA_pVir0042 
CjSA_pVir0013 
* = additional small RNAs predicted by Rockhopper present with differential expression; see S4, S5, and S6 Tables for additional information  
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In the ∆luxS mutant strain, one gene was found to be downregulated and 14 genes were 565 
found to be upregulated when compared to the IA3902 wild-type strain during exponential 566 
growth (summary Table 3, complete information Table F in S1 Appendix). Similar to the 567 
∆CjNC110 mutant, the previously described non-coding RNA CjNC140 was also found to be 568 
upregulated in the mutant condition during exponential growth only. At 12 hours, six genes were 569 
found to be downregulated and six upregulated in the ∆luxS mutant strain when compared to 570 
wild-type. Of the differentially expressed genes, only one gene, CjSA_1350, a putative 571 
methyltransferase, was found to be downregulated in the ∆luxS mutant during both exponential 572 
and stationary phases. Three separate operons predicted by Rockhopper demonstrated multiple 573 
genes within the operon affected by the mutant condition (two operons upregulated, one operon 574 
downregulated). Analysis of functionality via the COG database revealed that multiple both up- 575 
(trpF, trpB) and down- (CjSA_0620, leuC) regulated genes were present in the “Amino acid 576 
transport and metabolism” functional category; multiple upregulated genes were also included in 577 
the “Cell motility” (flgE, flgG2, flgG) functional category. Only two genes were differentially 578 
expressed in both the ∆CjNC110 and ∆luxS mutants, CjSA_0008 (upregulated during 579 
exponential growth hours) and CjSA_1107 (upregulated during stationary phase); both genes are 580 
annotated as hypothetical proteins at this time.  581 
In the ∆CjNC110∆luxS double knockout mutant, a large increase in both downregulated 582 
and upregulated genes when compared to wild-type was observed at both timepoints (summary 583 
Table 3, complete information Table G in S1 Appendix). Sixty-one protein coding genes, 584 
seventeen tRNA genes, three known ncRNA genes (tmRNA, SRP, 6S) and seven newly 585 
predicted ncRNAs were downregulated during exponential phase compared to IA3902 wild-type. 586 
In addition, 47 protein coding genes were upregulated in exponential phase, along with the 587 
previously described ncRNA CjNC140, which was also observed to be upregulated in the 588 
∆CjNC110 and ∆luxS single knockout mutants. During stationary phase, 32 genes and two 589 
newly predicted non-coding RNAs were found to be downregulated, while 29 genes were 590 
upregulated in the mutant strain when compared to wild-type. Of the observed genes with 591 
differential expression, many were observed to show altered expression during both exponential 592 
and stationary phase when compared to wild-type; however, most were differentially expressed 593 
in the opposite direction between the two timepoints. Only two genes (motB, CjSA_1350) were 594 
downregulated in both conditions, while no genes were observed to be upregulated at both 595 
timepoints. Many of the differentially upregulated genes demonstrated in both background 596 
mutants, ∆CjNC110 and ∆luxS, were observed in the double knockout (Figs 3A and 3B), while 597 
fewer of the downregulated genes were shared (Figs 4A and 4B).  598 
 599 
Fig 3. Venn diagram depicting the overlap of shared upregulated genes during the 600 
exponential and stationary growth phases. BioVenn was used to compare the lists of known 601 
genes upregulated in all 3 mutant strains during both exponential and stationary growth.  602 
 603 
Fig 4. Venn diagram depicting the overlap of shared downregulated genes during the 604 
exponential and stationary growth phases. BioVenn was used to compare the lists of known 605 
genes downregulated in all 3 mutant strains during both exponential and stationary growth.  606 
 607 
   Of the differentially expressed genes affected by the ∆CjNC110∆luxS double knockout 608 
mutation, 20 separate operons predicted by Rockhopper (predicted operon structure listed in 609 
Table J in S2 Appendix) demonstrated multiple genes within the operon affected by the mutant 610 
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condition (eight operons upregulated, four operons downregulated, and eight operons that 611 
showed opposing regulation at the different timepoints). Figure A in S3 Appendix shows the 612 
number of genes in each COG category that were differentially expressed in the double mutant 613 
condition during either exponential growth. The categories most affected by these mutations 614 
were “Energy production and conversion,” “Amino acid transport and metabolism,” 615 
“Translation,” “Cell wall/membrane biogenesis,” “Cell motility,” and “Signal transduction 616 
mechanisms.”   617 
KEGG Pathways was used to determine the effect of the mutations on important 618 
pathways in C. jejuni pathobiology. Figs 5A and 5B compare the genes observed to be 619 
differentially expressed in the double knockout mutant during both exponential and stationary 620 
phases for flagellar assembly. A large number of genes associated with flagellar assembly were 621 
noted to be differentially regulated in the double knockout mutant as compared to the single 622 
knockout mutants alone (Fig C in S3 Appendix).  623 
 624 
Fig 5. KEGG Pathway analysis demonstrates alteration of expression of multiple genes 625 
involved in flagellar assembly in C. jejuni in the ∆CjNC110∆luxS mutant during both 626 
exponential and stationary growth phases. Blue color indicates downregulation of gene 627 
expression, red color indicates up regulation of gene expression, green indicates that the gene is 628 
present in C. jejuni IA3902, and white indicates that the gene is not present in IA3902.  629 
 630 
Identification of additional non-coding RNAs in IA3902 631 
 In addition to determining differential gene expression between the mutant and wild-type 632 
strains of IA3902, Rockhopper has the capability to predict non-coding RNAs present within the 633 
data. Prior to further manual analysis, Rockhopper predicted a total of 59 ncRNAs present in the 634 
data (57 chromosomal, 2 pVir). Of those 59, five align with previously identified ncRNAs 635 
(CjNC20, CjNC60, CjNC120, CjNC140, CJpv2), all of which were predicted to be conserved in 636 
IA3902 by Dugar et al. [21]. Manual curation of the list decreased the number of predicted 637 
ncRNA candidates to 40 (Table H in S1 Appendix). Candidate non-coding RNAs were 638 
discarded if they were related to the 16S or 23S genes as these were thought to be spuriously 639 
identified due to Ribo-Zero depletion differences between replicates; in addition, a single 640 
antisense RNA was discarded due to incorrect annotation of the rnpB gene to the wrong strand in 641 
IA3902. Of those remaining, 6 were demonstrated transcripts in the region of genes annotated as 642 
pseudogenes in IA3902 (CjSA1052, CjSA1323, CjSA1444, CjSA1543 and CjSA1630 – 2 643 
separate ncRNA predictions). Two of the 40 remaining ncRNA candidates could potentially be 644 
classified as cis as they are transcribed opposite of transcribed regions of other genes; 25 would 645 
likely be considered trans ncRNAs as they are primarily located within intergenic regions; and 646 
seven are classified as anti-sense RNAs. 647 
 648 
TargetRNA2 and RNAFold predictions suggest potential targets and 649 
secondary structure of CjNC110 650 
The TargetRNA2 program predicted either 21 or 16 regulatory targets of CjNC110 in 651 
IA3902 based on the standard input parameters of the program and a 137 nt or 152 nt length, 652 
respectively (Table I in S1 Appendix). Of the predicted targets, only a single gene (CjSA_1137, 653 
annotated as an 2OG-Fe(II) oxygenase) was found to show significantly altered transcription in 654 
the CjNC110 mutant as compared to wild-type; this significant decrease was observed during 655 
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both exponential and stationary growth. This gene is located immediately downstream of 656 
CjNC110.  No genes were noted to overlap with the protein expression data. 657 
To assess secondary structure of the CjNC110, RNAFold was used to calculate the 658 
structure of CjNC110 using both the 137nt and 152nt predicted sizes, both of which yielded a 659 
prediction of a Y-shaped stem-loop structure (Fig 6). When comparing the Target2RNA data to 660 
the RNAFold predictions, all of the predicted interaction areas of the non-coding RNA were 661 
grouped into the 3 unpaired loop regions of the RNA structure.  662 
 663 
Fig 6. Structural prediction using RNAfold of the 137nt and 152 nt length options for 664 
CjNC110 RNA. For both the 137nt and 152nt predicted sizes, the structural prediction for 665 
CjNC110 contains 3 stem loops, with the unpaired loops being the region most likely to interact 666 
with mRNAs as predicted by TargetRNA2. 667 
 668 
qRT-PCR confirms RNAseq results that luxS is transcribed at 669 
higher levels in ΔCjNC110 when compared to IA3902 wild-type 670 
To further validate the results of the RNAseq and confirm that the increased expression 671 
of luxS in the ∆CjNC110 mutant was repeatable, qRT-PCR was performed on samples collected 672 
at 12 hours from the second growth curve using targets specific for the 3’ region of the luxS 673 
gene.  Fig 7 demonstrates the expression levels of luxS in the ∆CjNC110 mutant compared to 674 
wild-type and confirms that increased luxS mRNA levels are present during stationary phase in 675 
the mutant, resulting in a fold change increase of 3.20 when compared to IA3902 wild-type. 676 
Additionally, ΔCjNC110c was tested to determine if complementation of the mutation returned 677 
luxS to wild-type levels; interestingly, ΔCjNC110c also demonstrated a fold change increase of 678 
3.77 when compared to IA3902 wild-type.  One-way ANOVA with Tukey’s multiple 679 
comparison testing demonstrated significant fold change difference (p <0.05) in luxS 680 
transcription between both ΔCjNC110 and ΔCjNC110c when compared to IA3902 wild-type.   681 
 682 
Fig 7. qRT-PCR confirms luxS is transcribed at higher levels in the ΔCjNC110 and 683 
ΔCjNC110c backgrounds when compared to IA3902 wild-type (WT) (mean ± SEM).  C. 684 
jejuni cultures were collected at timepoint 12 hours for RNA conversion cDNA for qRT-PCR to 685 
assesses expression of mRNA luxS. Each bar represents the average fold change expression from 686 
three biological replicates. Significance is denoted by “*” above each timepoint.  687 
 688 
Growth of mutant strains during exponential growth is consistent 689 
with wild-type, but significant effects are seen in motility and 690 
autoagglutination 691 
The growth of IA3902 wild-type, ∆CjNC110, ∆luxS, and ∆CjNC110∆luxS was evaluated 692 
over a period of 30 hours and differences tested for statistical significance (p <0.05) using two-693 
way ANOVA with Dunnet’s repeated measures of the A600 readings at each time point. ANOVA 694 
did identify a statistically significant difference between strains in both growth curves (p <0.05), 695 
however, multiple comparison analysis of individual time points and strains when compared to 696 
wild-type growth revealed that the only significant difference was a decrease in the A600 of 697 
∆CjNC110 after 27 and 30 hours in both growth curves performed (Fig A in S3 Appendix and 698 
Fig 8). In both experiments, after 27 hours represents the point where a decline in the A600 begins 699 
to occur in all strains tested, and further examination of the actual CFU/mL over the course of 700 
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the first growth curve revealed that by 30 hours cell death was beginning to occur and colony 701 
counts were decreasing (Fig A in S3 Appendix ). As further growth is assumed to be ceased at 702 
this time, there is likely minimal biological significance to the finding of differences after 27 703 
hours in the assays performed using samples collected during exponential growth prior to 24 704 
hours, however, there is possibly biological significance to the difference noted during the 705 
stationary phase which may warrant further investigation.  706 
 707 
Fig 8. Shaking growth curve of wild-type IA3902 (WT) and isogenic mutants (mean ± 708 
SEM) confirm normal exponential growth. Results of four replicates (A600) of a shaking 709 
growth curve performed in 250 mL Erlenmeyer flasks under microaerophilic conditions in MH 710 
broth. Samples were pulled from this growth curve and used for qRT-PCR and AI-2 711 
bioluminescence assays. Significance is denoted by “*” above each timepoint. 712 
 713 
Motility of the mutant strains in semi-solid agar was compared to wild-type IA3902 at 30 714 
hours post-inoculation for all mutant isolates, and all isolates were confirmed to be highly motile 715 
(Fig 9). Statistical analysis via one-way ANOVA indicated that there was a significant difference 716 
between strains (p <0.0001).  Further post-hoc analysis via Tukey’s multiple comparisons test 717 
did not reach statistical significance (p>0.05) when comparing ∆CjNC110 to wild-type despite 718 
motility for the ∆CjNC110 strain observed to be consistently increased above the wild-type 719 
phenotype in all biological replicates performed.  Results did reach statistical significance 720 
(p<0.05), however, when comparing wild-type to both the ∆CjNC110∆luxS and ∆luxS mutants 721 
which displayed statistically significant decreased motility; this result is consistent with previous 722 
reports of decreased motility of luxS mutants in the IA3902 background [8].  As many of the 723 
strains had migrated to the edge of the plate by 30 hours, we hypothesized that by reading the 724 
plates sooner we may observe a larger difference in the motility of the ∆CjNC110 strain, 725 
therefore, a second set of experiments was performed with measurements taken at 24 hours post-726 
inoculation. When measured at 24 hours, motility for the ∆CjNC110 strain did demonstrate a 727 
statistically significant increase (p<0.05) when compared to all other strains tested, and motility 728 
of both the ∆CjNC110∆luxS and ∆luxS mutants was again noted to be significantly decreased.  729 
Following complementation of CjNC110, no significant difference was observed when 730 
compared to IA3902 wild-type in either experiment, confirming that complementation of 731 
CjNC110 quantitatively restored the phenotypic change back to wild-type levels. 732 
 733 
Fig 9. Motility assays confirm isogenic mutants remain motile, with ΔluxS motility 734 
decreased and ΔCjNC110 motility increased over IA3902 wild-type (mean± SEM).  Each 735 
bar represents the average motility of six biological replicates consisting of six technical 736 
replicates during each independent study. Significance is denoted by “*” above each bar when 737 
comparing wild-type to other respective strains at each independent timepoint.  738 
 739 
Autoagglutination activity was measured at 25ºC and 37ºC following 24 hours of 740 
incubation (Fig 10) with an increase in optical density correlating to decreased autoagglutination 741 
ability, and a decrease in optical density correlating to increased autoagglutination ability. A 742 
statistically significant difference (p <0.0001) between strains at both 25ºC and 37ºC was noted 743 
based on initial analysis via one-way ANOVA. When compared to IA3902 wild-type, 744 
autoagglutination activity for ∆luxS and ∆CjNC110∆luxS was noted to be increased at a 745 
statistically significant level (p<0.05) at both temperatures, while ∆CjNC110 exhibited 746 
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statistically significant decreased autoagglutination activity, again at both temperatures.  747 
Complementation of CjNC110 restored the autoagglutination ability of ΔCjNC110 to wild-type 748 
levels.  These results indicate that luxS and CjNC110 function to influence autoagglutination 749 
activity in opposing directions; interestingly, when mutation of both genes was combined, the 750 
results favored the ∆luxS mutation but did return closer to wild-type levels.  751 
 752 
Fig 10. ΔluxS bolsters autoagglutination and ΔCjNC110 hinders autoagglutination of 753 
IA3902 (mean± SEM). Autoagglutination as determined by optical density (A600) was measured 754 
following a 24 hour incubation at either 25°C or 37°C. Each bar represents the average 755 
autoagglutination of 4 biological replicates consisting of 3 technical replicates during each 756 
independent study. Significance is denoted by “*” above each bar when comparing wild-type to 757 
other respective strains at each independent timepoint.  758 
 759 
Vibrio harveyi bioluminescence assay demonstrates decreased 760 
extracellular AI-2 levels with a concomitant increase in intracellular 761 
AI-2 in ∆CjNC110  762 
 Bioluminescence activity was measured using the Vibrio harveyi assay as an 763 
approximation for extracellular (using E-CFS) AI-2 levels at various time points during the 764 
growth of IA3902 wild-type and mutant strains (Fig 11A). As expected, both the IA3902∆luxS 765 
and ∆CjNC110∆luxS mutant strains demonstrated no bioluminescence activity at any point 766 
during growth, indicating a complete lack of AI-2 production which is consistent with the 767 
absence of a functional LuxS protein. For the ∆CjNC110 mutant, bioluminescence was 768 
determined to be statistically significantly decreased when compared to wild-type at time points 769 
6, 9 and 12 hours (p <0.05) of the growth curve, occurring during mid to late exponential phase 770 
and early stationary phase.  Complementation of ∆CjNC110 completely restored extracellular 771 
AI-2 to wild-type levels. 772 
 773 
Fig 11. Bioluminescence activity as measured via the Vibrio harveyi bioassay over the 774 
course of growth (mean ± SEM) demonstrates (A) decreased extracellular AI-2 levels with 775 
(B) a concomitant increase in intracellular AI-2 in ∆CjNC110  Each bar represents the 776 
average RLU (AI-2 activity level) from three biological replicates consisting of three technical 777 
replicates each. Significance is denoted by “*” above each timepoint. 778 
 779 
 To determine if AI-2 production or transport across the cell membrane was impaired 780 
leading to this observed decrease in extracellular AI-2, the intracellular bioluminescence activity 781 
was also assessed utilizing I-CFS obtained from the cell pellet of the same culture as the E-CFS.  782 
Results of this assay demonstrated that intracellular AI-2 levels increased to statistically 783 
significant (p <0.05) levels in the ∆CjNC110 mutant when compared to IA3902 wild-type at 784 
both the 9 hour and 12 hour timepoints. (Fig 11B). Again, complementation of ∆CjNC110 785 
corrected the phenotypic alteration of increased intracellular AI-2 presence. These results 786 
indicate that the observed decrease in extracellular AI-2 activity is not due to impaired 787 
production, and instead suggests that transport of AI-2 across the cell membrane is altered in the 788 
∆CjNC110 mutant. 789 
 790 
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Liquid Chromatography with Tandem Mass Spectrometry confirms 791 
increased LuxS protein abundance in both ∆CjNC110 and 792 
∆CjNC110c 793 
Proteomic analysis was conducted to reveal the most highly abundant proteins and 794 
changes in their translational level at exponential phase of growth to compare to transcriptomic 795 
data. Whole protein extract LC-MS/MS analysis resulted in a total of 262 identified proteins that 796 
were discovered in each biological group. Two-way ANOVA with FDR correction identified 797 
statistically significant differences in protein abundance; these proteins are illustrated in Table 4. 798 
When comparing wild-type to ΔCjNC110, proteins ThiJ and FrdA had a statistically significant 799 
fold change difference of 19.7 and -11.3, respectively.  When comparing wild-type to 800 
ΔCjNC110c, proteins CjSA_0166 (lipoprotein) and RplN both had statistically significant fold 801 
change of -9.8, and RplU had a fold change of -4.9. In addition, proteins RecJ and AtpF 802 
demonstrated a statistically significant fold change of 8.0 and 9.2, respectively. There were 803 
several proteins that were identified as significantly different when comparing wild-type to both 804 
ΔCjNC110c and ΔCjNC110, including: LuxS, which exhibited increased expression, as well as 805 
CjSA_0067 (iron-sulfur protein) and CjSA_0489 (rhodanese-like domain-containing protein), 806 
both of which exhibited decreased expression in both backgrounds.  807 
 808 
Table 4: Significant differentially expressed proteins identified from proteomic analysis 809 
ΔCjNC110 and ΔCjNC110c versus IA3902 wild-type  810 
 
Geometric Mean 
(Abundance) 
  
Protein ID WT  Mutant  
Fold 
Change  
vs WT 
P-value* 
ΔCjNC110 
CjSA_0067 -  iron-sulfur protein 23726566.41 851708.3688 -27.9 <0.0001 
CjSA_0489 -  rhodanese-like domain-containing  35962749.77 2965820.801 -12.1 0.0001 
ThiJ - thiazole monophosphate synthesis protein 1589344.014 31307392.07 19.7 <0.0001 
FrdA - fumarate reductase flavoprotein subunit 3178688.029 280958.9826 -11.3 0.0002 
LuxS - S-ribosylhomocysteine lyase 3913424.009 50859008.46 13.0 <0.0001 
ΔCjNC110c 
CjSA_0067 - iron-sulfur protein 23726566.41 1123835.93 -21.1 <0.0001 
CjSA_0489 - rhodanese-like domain-containing  35962749.77 2767208.654 -13.0 0.0001 
CjSA_0166 – lipoprotein 25429504.23 2581896.969 -9.8 0.0006 
RplN - 50S ribosomal protein L14 10327587.87 1048576 -9.8 0.0007 
RplU - 50S ribosomal protein L21 15653696.03 3178688.029 -4.9 0.0007 
RecJ - single-stranded-DNA-specific exonuclease 2408995.053 19271960.42 8.0 0.002 
AtpF - ATP synthase subunit B 2965820.801 27254667.8 9.2 0.001 
LuxS - S-ribosylhomocysteine lyase 3913424.009 54509335.6 13.9 <0.0001 
CjSA_0926 -  lipoprotein 1703416.738 23726566.41 13.9 0.0001 
 Geometric mean calculated by backtransforming log2 transformation value 
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 811 
Hierarchical heat maps also reveal contrasting protein expression patterns when 812 
comparing IA3902 wild-type to ΔCjNC110 and ΔCjNC110c. The top 20 hierarchical clustered 813 
proteins are illustrated for both ΔCjNC110 and ΔCjNC110c compared to wild-type IA3902 in 814 
Fig 12. Heat maps can provide meaningful clusters of data that can drive biomarker discovery 815 
that may not be picked up by a stricter statistical-based test, and can also shrink the data to find 816 
the most meaningful changes in the dataset. We note overlap between FDR significant proteins 817 
and proteins identified after heat map analysis, including ThiJ, LuxS, CJSA_0489, and 818 
CJSA_0166. Several additional proteins were identified via this approach that did not reach the 819 
FDR threshold for significance but exhibited clear differences in translational patterns when 820 
compared to IA3902 wild-type. In the ΔCjNC110 background, protein PycB demonstrated 821 
increased expression when compared to IA3902 wild-type, while proteins with decreased 822 
expression included CJSA_0387, CJSA_1389, NifU, FlaA, FlgD, and RpoZ. In addition, various 823 
proteins classified as periplasmic (CjSA_0190, CjSA_0854, CjSA_1107, CjSA_1178, 824 
CjSA1419, and CjSA1577) and lipoprotein (CjSA_0969) also exhibited decreased expression 825 
compared to wild-type. Complementation of the CjNC110 mutation resulted in reversal of these 826 
expression changes for all of the proteins described with the notable exception of LuxS which 827 
exhibited increased expression in both backgrounds; this finding was consistent with the results 828 
of the qPCR which demonstrated increased gene expression of luxS in both strains.  829 
 830 
Fig 12. Heatmaps reveal differential protein clustering patterns induced in both ΔCjNC110 831 
and ΔCjNC110c when compared to IA3902 wild-type (WT). All raw abundances were 832 
normalized, imputated, transformed to log2 scale values, and clustered based on resulting 833 
hierarchical patterns. The top 20 proteins were grouped and analyzed using heat map settings: 834 
distance measurement of Elucidean and average clustering algorithm.  835 
 836 
Colonization of chickens is impaired in the ∆CjNC110 and absent in 837 
∆luxS and ∆CjNC110∆luxS mutants, but is restored to wild-type 838 
colonization levels in ∆CjNC110c 839 
 To determine if mutation of ∆CjNC110, ∆luxS and ∆CjNC110∆luxS affected the ability 840 
of IA3902 to colonize chickens, cecal colonization levels were monitored for 3 weeks following 841 
oral inoculation of approximately 200 µl of 1x10
7
 CFU per strain.  On DPI 5, a statistically 842 
significant decrease in colonization was noted for both the ∆CjNC110 and ∆luxS strains 843 
compared to wild-type; complementation of the ∆CjNC110 mutant restored colonization to wild-844 
type levels (Fig 13).  On DPI 12 and 19, a statistically significant decrease in colonization was 845 
noted for the ∆CjNC110, ∆luxS, and ∆CjNC110∆luxS strains compared to wild-type with no 846 
colonization of ∆luxS and ∆CjNC110∆luxS apparent at these time points; complementation of 847 
the ∆CjNC110 mutant again restored colonization levels to wild-type levels for both DPI 12 and 848 
19.  These results indicate that the presence of CjNC110 is necessary for optimal colonization, 849 
while luxS is required for colonization of IA3902 in chickens.   850 
 851 
Fig 13. Chicken colonization is impaired in ∆CjNC110 and absent in ∆luxS and 852 
∆CjNC110∆luxS mutants compared to wild-type (mean ± SEM). Results are reported as log10 853 
CFU/mL of ceca content for each sampling day [DPI 5 (Week 1), DPI 12 (Week 2), and DPI 19 854 
 *Two-way ANOVA FDR set at 0.05 
WT = wild-type 
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(Week 3)]. Each bar represents the average colonization levels for each biological group with 855 
weekly technical replicates using a minimum of 6 birds.  Significance is denoted by “*” above 856 
each timepoint. 857 
 858 
Discussion 859 
Over the past several years, RNAseq has become the method of choice to analyze the 860 
transcriptome of bacteria under various conditions as it allows evaluation of the entire 861 
transcriptome rather than only previously annotated regions as with older technology such as 862 
microarrays [58-60]. Recent work in Campylobacter has demonstrated that RNAseq can be 863 
useful for analyzing transcriptomic differences between wild-type and mutant strains following 864 
inactivation of protein-coding genes [61, 62]. In theory, RNAseq should also be able to be 865 
utilized for the same purpose of discovering the global effects of inactivation of ncRNAs. Small 866 
RNAs have been shown to be able to stabilize mRNA transcripts by multiple mechanisms [63], 867 
which should lead to increased levels of transcript availability and identification using RNAseq. 868 
In contrast, some interactions with ncRNAs have also been shown to increase transcript turnover 869 
by targeting transcripts for RNase degradation or exposing RNase cleavage sites [63], which 870 
should lead to decreased levels of transcripts available for identification via RNAseq. Thus, 871 
assessment of differential gene expression via RNAseq should be useful for uncovering 872 
interactions of ncRNAs with their targets that directly leads to altered levels of mRNA 873 
transcripts in the cell.  One limitation of the use of RNAseq data for discovery of targets of small 874 
RNAs is that some target interactions may not lead to direct changes in mRNA transcript levels 875 
but instead affect the translation efficiency of the target mRNA; these types of interactions 876 
cannot be determined via this approach. Therefore, use of multiple additional methods such as 877 
computational approaches and proteomics to determine additional potential targets of ncRNAs is 878 
also warranted.  The results of our work clearly indicate that RNAseq can be a useful tool for 879 
investigating the role of ncRNAs in gene expression in bacteria and can successfully be used to 880 
inform the design of phenotypic studies to begin to elucidate the function of ncRNAs in 881 
pathogenic bacteria. 882 
During stationary phase in the ∆CjNC110 mutant, expression of the luxS mRNA was 883 
determined to be statistically significantly upregulated when compared to wild-type using 884 
RNAseq; during exponential growth, increased expression was also present but did not reach 885 
statistical significance. This initially suggested that CjNC110 may normally interact with the 886 
luxS transcript to impact AI-2 expression and quorum sensing.  qRT-PCR confirmed the 887 
observed increase in luxS transcription seen via RNAseq, and increased expression of the LuxS 888 
protein was also observed via LC-MS/MS, clearly indicating that the response to the loss of 889 
CjNC110 expression was to increase LuxS protein production.  However, further investigation 890 
revealed that despite the increased luxS expression and LuxS protein abundance in the CjNC110 891 
mutant, AI-2 extracellular concentrations were decreased. This defect was corrected via 892 
complementation of CjNC110 despite the fact that luxS expression and LuxS protein abundance 893 
remained increased in the complement.  The reason for the increased luxS expression and LuxS 894 
protein abundance in CjNC110c is currently unknown but is most likely related to additional 895 
unknown effects of CjNC110 on the AMC due to constitutive expression of CjNC110 in the 896 
complement.  The increased luxS expression and LuxS protein abundance in the CjNC110c, 897 
combined with complementation back to wild-type of extracellular AI-2 activity, does clearly 898 
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demonstrate, however, that a change in LuxS protein abundance is not the cause of the observed 899 
difference in extracellular AI-2 concentrations.   900 
Having ruled-out decreased LuxS abundance as a cause for the decreased extracellular 901 
AI-2, potential hypotheses for the observed difference included either decreased production of 902 
AI-2 by LuxS, increased degradation of AI-2, or altered kinetics of AI-2 movement into or out of 903 
the extracellular environment.  To assess for altered kinetics of AI-2 movement, intracellular AI-904 
2 levels were measured in the ∆CjNC110 mutant compared to wild-type and revealed an 905 
accumulation of AI-2 intracellularly in ∆CjNC110 that was corrected to wild-type levels in 906 
∆CjNC110c.  This indicates that impairment of AI-2 transport out of or increased import into the 907 
cell was the reason for the observed decrease in extracellular AI-2 in the CjNC110 mutant, and 908 
not decreased production or increased degradation.  In E. coli, the YdgG (TqsA) protein, part of 909 
the AI-2 exporter superfamily, has been described to export AI-2 molecules [64].  To date, 910 
however, no similar homologue has been found in C.jejuni.  Previous BlastP analysis has shown 911 
additional potential homologues of the YdgG protein exist within the Campylobacterales family, 912 
but none directly within the C. jejuni species [65].  Within our proteomics data, several 913 
periplasmic and lipoproteins which could be located in the cytoplasmic membrane were 914 
identified to exhibit decreased expression in ∆CjNC110 that was corrected to wild-type levels in 915 
∆CjNC110c.  The function of many of these proteins has yet to be elucidated in Campylobacter, 916 
therefore, future work assessing whether these proteins could serve as an AI-2 exporter in C. 917 
jejuni is warranted. In other species of bacteria such as E. coli, uptake of AI-2 from the 918 
extracellular environment has also been shown to be mediated by an active LSR system [66]. 919 
Comparative genomics has again failed to identify a homologous AI-2 uptake system in C. 920 
jejuni, however, several ABC-type transporters whose function remains to be elucidated do exist 921 
in Campylobacter sp. [27].  Several studies evaluating the concentration of AI-2 over time 922 
following addition of exogenous AI-2 to cell culture have attempted to determine whether or not 923 
AI-2 is able to be internalized in C. jejuni with mixed results [67, 68].  Thus, further research 924 
into an AI-2 uptake system in C. jejuni may also be warranted. 925 
Interestingly, analysis of transcriptome changes in the ∆luxS mutant were not as 926 
enlightening as was expected.  The list of genes identified does not overlap with the list of 927 
differentially expressed genes generated via microarray in C. jejuni strain 11168 which utilized 928 
the exact same mutant construct that was moved via homologous recombination into IA3902 929 
[69]; however, differences in the strain of C. jejuni utilized in this study (IA3902) and culture 930 
conditions may explain why there was no overlap of differentially expressed genes. No genes 931 
associated with the AMC pathway were identified in our RNAseq data as have been previously 932 
reported via microarray in other strains of C. jejuni [70], however, there was very minimal 933 
expression of many of the genes associated with the AMC pathway in our data (metE, metF, pfs) 934 
which may have led to an inability to detect a difference. Decreased transcription of flaA has 935 
previously been associated with luxS mutation in strain 11168 [71]; expression of flaA during 936 
exponential growth was decreased 1.4-fold compared to wild-type, however, this change was not 937 
found to be statistically significant; no difference was present in flaA levels during stationary 938 
growth. A single gene, CjSA_1350, which is annotated as a putative methyltransferase, was 939 
found to be down-regulated during both exponential and stationary growth in the ∆luxS mutant 940 
of IA3902. The LuxS enzyme is critical for the formation of S-adenosylmethionine (SAM), 941 
which is a major methyl donor necessary for methylation of DNA, proteins, carbohydrates and 942 
other molecules important to the physiology of prokaryotes [72]. It is plausible that expression of 943 
this methyltransferase is sensitive to decreased availability of products from the activated methyl 944 
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cycle due to luxS mutation; however, recent data generated within our lab group suggests that 945 
this gene does not encode an active methyltransferase in IA3902 [73]. No change was detected in 946 
the expression of CjNC110 in the ∆luxS construct, however, an additional ncRNA, CjNC140, 947 
was noted to exhibit increased expression during exponential growth phase. 948 
  In distinct contrast to the lack of similar findings to previous studies exhibited by the 949 
IA3902∆luxS mutant, when the ∆CjNC110 and ∆luxS mutations were combined into a double 950 
knockout mutant (∆CjNC110∆luxS), many of the previously noted transcriptional changes 951 
attributed to mutation of the luxS gene alone became apparent [70]. The He et al. [70] study was 952 
performed in a different strain of C. jejuni, 81-176, which also encodes and expresses CjNC110 953 
[21]. After attempting to compare various strains and methods of mutation of the luxS gene and 954 
finding wide variation in phenotypical and transcriptional changes, Adler et al. [28] suggested 955 
that some of the differences reported between luxS mutants in various studies may be due to 956 
unknown polar affects caused by alteration of expression of CjNC110 based on the mutation 957 
strategy used for the luxS mutation. It seems highly likely based on the data generated in our 958 
study that some of the changes attributed to luxS mutation alone in the He et al. [70] study may 959 
in fact be due to inactivation of the CjNC110 transcript as well. Of the 57 genes listed as 960 
differentially expressed by the luxS mutant in He et al.[70], 21 were also found to be 961 
differentially expressed in our ∆CjNC110∆luxS RNAseq data; again, none were found to be 962 
differentially expressed only in the ∆luxS mutant, while in contrast, three genes (tpx, ptmB, 963 
ptmA) were differentially expressed only in the ∆CjNC110 mutant. Of the 21 overlapping genes, 964 
only the flagellar genes flgE, flgG2, and flgG were differentially expressed in both the ∆luxS and 965 
∆CjNC110∆luxS mutants. These findings strongly suggest that in the previous study the main 966 
driver for the transcriptional changes seen was an inadvertent inactivation of both CjNC110 and 967 
luxS, and not luxS alone. Of the genes identified in both our study and He et al. [70], a large 968 
number of the hook-basal body associated proteins (FlgD, FlgE, FlgG, FlgG2, FlgH, FlgI, and 969 
FlgK) that are under the control of σ54 (RpoN) promotors [74, 75] were identified. Expression 970 
from σ54 promotors has been shown to require activation of the FlgRS two-component regulatory 971 
system [74, 76]. Many of these showed opposite differences based on growth phase (decreased 972 
exponential, increased stationary), and it has been previously demonstrated that regulation by 973 
these sigma-factors is growth cycle dependent, with σ54-regulated genes typically expressed 974 
between σ70- and σ28-associated genes [74], which may help explain the differences seen here. Of 975 
particular note is the fact that flgS was observed to be upregulated in the ∆CjNC110∆luxS 976 
mutant. It has been previously suggested that an additional unknown factor may control the 977 
temporal regulation of σ54 dependent flagellar genes [77]; therefore, it is reasonable to consider 978 
based on our results that luxS or CjNC110 may play a role in this regulation.  979 
Several additional phenotypes of interest were identified in our research, including 980 
alteration of the ability to colonize chickens by ∆CjNC110, ∆luxS and ∆CjNC110∆luxS.  The 981 
abolishment of the ability of ∆luxS to colonize chickens has previously been described in 982 
IA3902 but not in NCTC 11168; the reason for this difference is currently unknown, but has 983 
been speculated to be related to strain-specific differences in the metabolism of methionine or S-984 
adenosylmethionine (SAM) recycling which are also affected by the luxS mutation [27].  985 
Additional work in our lab has shown that the luxS mutation in IA3902 does disrupt the AMC, 986 
which functions to recycle SAM and produce methionine [49], however, DNA methylation in 987 
IA3902 was not affected by the luxS mutation [73].  Comparative genomics reveals that NCTC 988 
11168 does harbor an additional genomic system for methionine biosynthesis in the form of 989 
metAB which is not present in IA3902 and may represent an alternative pathway for synthesis of 990 
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this required amino acid and an explanation for the observed difference in colonization ability.  991 
Mutation of ∆CjNC110 in our work also led to a significantly decreased colonization ability in 992 
IA3902 compared to wild-type, indicating that this ncRNA has the potential to play a key role in 993 
modulating colonization by C. jejuni. Further work is ongoing in our lab to determine if mutation 994 
of CjNC110 in NCTC 11168 also displays a colonization defect, or, if similar to luxS, the 995 
phenotype differs from IA3902. 996 
Motility is considered critical for the in vivo virulence of C. jejuni and requires a 997 
functional flagellar apparatus [78, 79]; however, this alone is not sufficient for normal motility to 998 
be present [80]. In our study, a statistically significant increase in motility was found between the 999 
∆CjNC110 mutant and wild-type when motility was assessed at 24 hours rather than 30 hours. 1000 
Interestingly, when assessing the transcriptomics data, the cetAB operon (Campylobacter energy 1001 
taxis proteins A and B), which is known to mediate energy taxis response in Campylobacter 1002 
[81], was statistically significantly upregulated in the ∆CjNC110 mutant when compared to wild-1003 
type during the exponential phase of growth. Expression of cetAB was increased during the 1004 
stationary phase as well, however, did not reach the level of statistical significance. Defects in 1005 
both cetA and cetB have been shown to lead to altered motility phenotypes, particularly in 1006 
response to migration towards critical factors in Campylobacter metabolism such as sodium 1007 
pyruvate and fumarate [80]. Investigation of expression of cetA and cetB has shown that levels of 1008 
the gene products are unaffected by mutation of sigma factors σ54 or σ28, indicating that 1009 
transcription of the cetAB operon is likely controlled by σ70 or another yet unknown transcription 1010 
factor [81]. Based on this information, it seems plausible that CjNC110 might normally act as a 1011 
repressor of the CetAB energy taxis system. Attempts to determine the location of the interaction 1012 
between the cetAB operon and CjNC110 using computational prediction programs such as 1013 
TargetRNA2 failed to identify an interaction region, however, computational methods of target 1014 
identification are particularly unrewarding in non-model organisms such as Campylobacter due 1015 
to a lack of conservation of small RNAs in these species [18]. Our proteomics data also failed to 1016 
detect the CetA and CetB proteins, therefore, we could not validate that increased expression of 1017 
cetA and cetB resulted in increased protein expression levels.  Many of the proteins identified in 1018 
our study exhibited extremely high expression levels, which, without fractioning, prevented 1019 
proteins of lesser abundance from being detected. Whole cell proteomic analysis with fractioning 1020 
and time-course analysis would be required to reveal the entire proteomic network regulated by 1021 
CjNC110 and validate expression patterns of proteins of lesser abundance than the 262 proteins 1022 
that were identified in our study.  Further work to determine if an interaction between CjNC110 1023 
and the cetAB operon exists and leads to increased expression of the CetA and CetB proteins is 1024 
warranted.  1025 
 Minimal changes in genes associated with the flagellar apparatus were noted in the 1026 
transcriptome of ∆CjNC110 which may also help to explain why an increase in energy taxis 1027 
would allow for an increase in observed motility with the assumption that normally functioning 1028 
flagella are present. In contrast to the ∆CjNC110 strain, however, both the ∆luxS and 1029 
∆CjNC110∆luxS mutants did display altered expression of genes associated with the flagellar 1030 
apparatus during at least one stage of growth.  For the ∆luxS mutant, a small number of flagellar 1031 
associated genes were observed to be upregulated during stationary growth. No additional genes 1032 
known to be related to motility in C. jejuni appeared to be affected by the luxS mutation; 1033 
therefore, a reasonable explanation for the decreased motility cannot be ascertained from this 1034 
data alone. For the ∆CjNC110∆luxS mutant, however, there were a large number of genes 1035 
involved in assembly of the flagellar apparatus that demonstrated dysregulation when both the 1036 
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luxS and CjNC110 mutations were combined. Many genes related to flagellar assembly were 1037 
decreased in expression during exponential growth; however, the same genes were increased in 1038 
expression during stationary growth. Our data in this study demonstrated a statistically 1039 
significant decrease in motility of the ∆CjNC110∆luxS mutant when compared to both wild-type 1040 
and the ∆CjNC110 mutant. This suggests that the decrease in motility is unrelated to the 1041 
CjNC110 mutation when present by itself, but when both the ∆luxS and ∆CjNC110 mutations 1042 
are combined, the effect of decreased motility observed in the luxS mutation is maintained.  1043 
 The presence of normal flagella has also been associated with autoagglutination ability 1044 
and is considered necessary but not sufficient for this important trait [80]. Previous studies in C. 1045 
jejuni have demonstrated that interactions between modifications on adjacent flagellar filaments, 1046 
particularly those provided by protein glycosylation, are required for normal autoagglutination 1047 
ability [82]. In addition, mutants defective in autoagglutination ability have also been shown to 1048 
display a decrease in adherence and invasion ability in vitro as well as attenuation in disease 1049 
models [82]. In the present study, the ∆CjNC110 mutant exhibited decreased autoagglutination 1050 
when compared to wild-type at both 25ºC and 37ºC. Interestingly, two genes that have been 1051 
associated with flagellar glycosylation, ptmA and neuB2, were downregulated in our RNAseq 1052 
data in the ∆CjNC110 mutant when compared to wild-type during both exponential and 1053 
stationary growth phases. The ptmA and neuB2 genes have been previously shown to be involved 1054 
in production of Leg5Am7Ac and PseAm, two important structural glycans involved in flagellar 1055 
glycosylation in C. jejuni [83, 84]. A decrease in the amount of flagellar glycosylation related to 1056 
decreased production of these genes could in theory lead to decreased autoagglutination ability. 1057 
The fact that we observed a decrease in autoagglutination activity in the ∆CjNC110 mutant, 1058 
combined with RNAseq data indicating a decrease in the presence of the mRNA transcripts of 1059 
the genes ptmA and neuB2 that affect flagellar glycosylation, suggests that these findings 1060 
represent a true phenotypic change in the CjNC110 mutant and an additional potential area of 1061 
regulation for the CjNC110 non-coding RNA. In this case, and in contrast to the cetAB operon 1062 
where removal of CjNC110 led to an increase in expression, inactivation of CjNC110 led to a 1063 
decrease in the expression of these two genes which were predicted to belong to the same operon 1064 
in our Rockhopper analysis. In other bacterial species, small ncRNAs have been shown to lead to 1065 
stabilization of the target mRNA [85]. This suggests that CjNC110 may normally serve in trans 1066 
to prevent degradation of the ptmA and neuB2 mRNA transcripts after they have been produced, 1067 
leading to increased longevity of the mRNA and thus increasing levels of the translated protein. 1068 
By removing CjNC110, stabilization of the mRNA message of ptmA and neuB2 may not occur 1069 
as normal, leading to increased turnover of the message and decreased protein production. Again, 1070 
attempts to determine the location of the interaction between ptmA, neuB2 and CjNC110 using 1071 
computational prediction programs such as TargetRNA2 failed to identify an interaction region, 1072 
and our proteomics data failed to identify either protein.  1073 
In contrast to ∆CjNC110, the ∆luxS mutant exhibited statistically significant increased 1074 
autoagglutination at both 25°C and 37°C. This finding is the opposite of what was observed in a 1075 
different strain of C. jejuni, 81-176, where the luxS mutation led to a decrease in 1076 
autoagglutination ability [71]. Mutation of the luxS gene by Jeon et al. [71] was accomplished 1077 
using the same method as He et al. [70], thus it is plausible that the results obtained may also be 1078 
a result of the luxS gene inactivation in combination with polar affects to CjNC110. However, 1079 
there are also known differences between strains of C. jejuni in the type of flagellar glycosylation 1080 
present, particularly between NCTC 11168 (considered sytenic to IA3902) and 81-176, which 1081 
may help to further explain the differences observed between autoagglutination studies 1082 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity.preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for this. http://dx.doi.org/10.1101/2020.01.02.893479doi: bioRxiv preprint first posted online Jan. 3, 2020; 
performed using different C. jejuni strains [86].  It is unclear at this time what mechanism 1083 
allowed for increased autoagglutination ability in the ∆luxS mutant in this particular strain of C. 1084 
jejuni. In addition, while these changes in autoagglutination are statistically significant, the 1085 
biological relevance at this time is unknown, particularly as decreased to absent colonization of 1086 
chickens was again confirmed in this mutant. When measured in terms of percent of normal 1087 
autoagglutination of the IA3902 wild-type strain, for the ∆luxS mutant, autoagglutination ability 1088 
was observed to be 172% and 168% of the wild-type at 25°C and 37°C, respectively. For the 1089 
∆CjNC110 mutant, autoagglutination was observed to be 53% at 25°C and 56% at 37°C of the 1090 
wild-type. Following complementation of CjNC110, on a percentage basis autoagglutination 1091 
levels were much closer to wild-type demonstrating autoagglutination activity of 101% at 25ºC 1092 
and 107% at 37ºC.  However, when compared to the percentage of autoagglutination possible, 1093 
which would be considered 100% at an A600 of 0.00 and 0% at an A600 of 1.0, both the wild-type 1094 
and mutant strains still exhibited a relatively high ability to autoagglutinate. For comparison, 1095 
mutations in the flaA/flaB and flbA genes of C. jejuni strain 81-176 led to a decrease from A600 1096 
0.031 (96.9%) to 0.731 (24.9%) and 0.654 (35.6%), respectively [52]. While not reflected in the 1097 
transcriptomic data, our proteomic heat map data did show a decrease in FlaA translation in 1098 
ΔCjNC110, thus it is possible that the decreased autoagglutination observed in this mutant may 1099 
also be related to a decrease in FlaA protein abundance [52]. Differences in virulence displayed 1100 
in both in vitro and in vivo models are likely to be expected with such dramatic changes in AAG 1101 
activity as displayed in the flaA/flab and flbA mutations.  As neither the luxS gene nor the 1102 
CjNC110 are known to be directly involved in flagellar glycosylation, it seems reasonable that 1103 
inactivation of these genes could lead to a modification of autoagglutination ability without 1104 
complete loss or gain of function.  Further work including assessment for changes in the flagellar 1105 
glycosylation of these mutants when compared to the IA3902 wild-type and additional in vitro 1106 
and in vivo analysis of flagellar glycosylation is warranted.  1107 
Several additional putative ncRNAs were also identified via the Rockhopper program 1108 
which allowed for confirmation of expression of five non-coding RNAs conserved among 1109 
Campylobacter species that were previously predicted to be present in IA3902 [21]. The majority 1110 
of the other identified putative non-coding RNAs that were predicted by the program have not 1111 
been previously reported in C. jejuni. Based on the data presented in Dugar et al. [21] that 1112 
suggests that many small RNAs in Campylobacter are strain-specific, the fact that the predicted 1113 
RNAs were not previously identified does not mean that they are not real. That being said, there 1114 
are limitations to the identification of non-coding RNAs by Rockhopper. One-third of the 1115 
initially predicted ncRNAs were manually discarded as they mapped to the region of the 16S or 1116 
23S genes and were likely identified due to differences between replicates in Ribo-Zero rRNA 1117 
depletion efficiency. Another subset of the identified non-coding RNAs were recognized by the 1118 
program because the genome file utilized by Rockhopper does not include pseudogenes, 1119 
therefore, reads that mapped to areas of putative pseudogenes were classified as non-coding 1120 
RNA. While it is possible that these transcripts no longer serve as functional mRNA transcripts 1121 
and now instead act as functional non-coding RNAs, it is probably more likely that these 1122 
transcripts either do form functional proteins or are simply a non-functional remnant of what 1123 
once was a functional protein-coding message.  1124 
While not explored further in our phenotypic studies, Rockhopper did identify two 1125 
additional non-coding RNAs, CjNC140 and CjNC130/6S, as being differential expressed in our 1126 
mutants; these ncRNAs have been previously identified and confirmed to be transcribed in 1127 
multiple other Campylobacter species [21]. Of particular interest is the CjNC140 non-coding 1128 
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RNA. Predicted to be transcribed in the intergenic region upstream of porA, this ncRNA was 1129 
upregulated during exponential growth in all three of the mutant strains when compared to wild-1130 
type (Fig D in S3 Appendix). As increased expression was not observed during stationary 1131 
growth, this suggests that CjNC140 may serve as a regulator involved in mediating changes 1132 
during different stages of bacterial growth. The fact that its expression is similarly altered under 1133 
all 3 mutant conditions also suggests that the three genes, luxS, CjNC110 and CjNC140, may 1134 
normally interact within the cell in some way to facilitate these changes.  Point mutations in the 1135 
nearby porA have also been recently determined to be sufficient to cause the abortion phenotype 1136 
[10], making this ncRNA particularly interesting for further study.  Futher work is ongoing in 1137 
our lab to determine the role of CjCN140 in the pathophysiology of C. jejuni as well. 1138 
 1139 
Conclusion 1140 
 The results of our research clearly demonstrate a significant role for CjNC110 in the 1141 
pathobiology of C. jejuni IA3902.  The collective results of the phenotypic and transcriptomic 1142 
changes observed in our data complement each other and suggest that CjNC110 may be involved 1143 
in regulation of energy taxis, flagellar glycosylation, cellular communication via quorum 1144 
sensing, and chicken colonization in C. jejuni IA3902. This work provides for the first time 1145 
valuable insights into the potential regulatory targets of the CjNC110 small RNA in the zoonotic 1146 
pathogen C. jejuni and suggests a wide range of research avenues into the role of non-coding 1147 
RNAs in the pathobiology of this important zoonotic pathogen. 1148 
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Fig A. Shaking growth curve utilized for RNA extraction for RNAseq of wild-type 1557 
IA3902 and isogenic mutants (mean ± SEM). A600 (A) and log10 CFU/mL (B) results 1558 
of four replicates of a shaking growth curve performed in 250 mL Erlenmeyer flasks 1559 
under microaerophilic conditions in MH broth. Analysis via two-way ANOVA revealed a 1560 
statistically significant difference between strains (p <0.05), however, multiple 1561 
comparison analysis of individual time points and strains when compared to wild type 1562 
growth revealed that the only time point where the differences was considered to be 1563 
statistically significant was at 30 hours for all strains (denoted by *).   1564 
 1565 
Fig B. COG functional categories of differentially expressed genes in the 1566 
∆CjNC110∆luxS mutant. Clusters of Orthologous Groups (COG) categories are 1567 
indicated on the x-axis, with the number of genes enriched shown on the y-axis; blue bars 1568 
indicate increased expression, red bars indicate decreased expression. C - Energy 1569 
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production and conversion; D - Cell cycle control, mitosis and meiosis; E - Amino acid 1570 
transport and metabolism; F - Nucleotide transport and metabolism; G - Carbohydrate 1571 
transport and metabolism; H - Coenzyme transport and metabolism; I - Lipid transport 1572 
and metabolism; J – Translation; K – Transcription; L - Replication, recombination and 1573 
repair; M - Cell wall/membrane biogenesis; N - Cell motility; O - Posttranslational 1574 
modification, protein turnover, chaperones; P - Inorganic ion transport and metabolism; 1575 
Q - Secondary metabolites biosynthesis, transport and catabolism; R - General function 1576 
prediction only; S - Function unknown; T - Signal transduction mechanisms; U - 1577 
Intracellular trafficking and secretion; V - Defense mechanisms; W - Extracellular 1578 
structures 1579 
 1580 
Fig C. KEGG Pathway for flagellar assembly in C. jejuni: genes affected by the 1581 
single mutation of either ∆CjNC110 (A) or ∆luxS (B) mutation during stationary 1582 
growth phase. Blue color indicates downregulation of gene expression, red color 1583 
indicates up regulation of gene expression, green indicates that the gene is present in C. 1584 
jejuni IA3902, and white indicates that the gene is not present in IA3902. 1585 
 1586 
Fig D. Graphic view of CjNC140 expression from RNAseq. (A) A screen capture from 1587 
IGV of the porA and CjNC140 regions of the genome, corresponding to the genome 1588 
structure as depicted in (B), of all of the strains sequenced using RNAseq.   1589 
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